EU Local Number;Report Type;EV Gateway Receipt Date;Primary Source Qualification;Primary Source Country for Regulatory Purposes;Literature Reference;Patient Age Group;Patient Age Group (as per reporter);Parent Child Report;Patient Sex;Reaction List PT (Duration – Outcome - Seriousness Criteria);Suspect/interacting Drug List (Drug Char - Indication PT - Action taken - [Duration - Dose - Route]);Concomitant/Not Administered Drug List (Drug Char - Indication PT - Action taken - [Duration - Dose - Route]);ICSR Form
EU-EC-10010263229;Spontaneous;2021-10-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Cough (n/a - Not Recovered/Not Resolved - ),<BR><BR>Crying (n/a - Recovering/Resolving - ),<BR><BR>Initial insomnia (n/a - Recovering/Resolving - ),<BR><BR>Laryngitis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Poor feeding infant (n/a - Recovering/Resolving - ),<BR><BR>Rhinorrhoea (n/a - Not Recovered/Not Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010263229&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010265417;Spontaneous;2021-10-08 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Infantile spasms (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - n/a - n/a - [n/a - n/a - Oral]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010265417&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010266745;Spontaneous;2021-10-08 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Hyperlactacidaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hyperleukocytosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Thrombocytosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010266745&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010245071;Spontaneous;2021-10-07 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Faeces discoloured (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyperpyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010245071&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010245325;Spontaneous;2021-10-07 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010245325&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010249993;Spontaneous;2021-10-07 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site swelling (4d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010249993&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010251265;Spontaneous;2021-10-07 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Body temperature decreased (30d - Recovered/Resolved - ),<BR><BR>Body temperature increased (4d - Recovered/Resolved - ),<BR><BR>Cold sweat (30d - Recovered/Resolved - ),<BR><BR>Extensive swelling of vaccinated limb (30d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Peripheral coldness (30d - Recovered/Resolved - ),<BR><BR>Product quality issue (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010251265&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010230373;Spontaneous;2021-10-06 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Aphasia (n/a - Unknown - ),<BR><BR>Asthenia (n/a - Unknown - ),<BR><BR>Clumsiness (n/a - Unknown - ),<BR><BR>Dopa-responsive dystonia (n/a - Not Recovered/Not Resolved - ),<BR><BR>Fatigue (n/a - Unknown - ),<BR><BR>Gait inability (n/a - Unknown - Other Medically Important Condition),<BR><BR>Inappropriate schedule of product administration (n/a - Unknown - ),<BR><BR>Mobility decreased (n/a - Unknown - ),<BR><BR>Motor dysfunction (n/a - Unknown - ),<BR><BR>Posture abnormal (n/a - Unknown - ),<BR><BR>Psychomotor retardation (n/a - Not Recovered/Not Resolved - ),<BR><BR>Psychomotor skills impaired (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010230373&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010230887;Spontaneous;2021-10-06 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - n/a - [n/a - .5mL - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010230887&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010231093;Spontaneous;2021-10-06 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Diabetes mellitus (n/a - Not Recovered/Not Resolved - Disabling);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - Unknown - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010231093&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010236583;Spontaneous;2021-10-06 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Haematochezia (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Mucous stools (n/a - Recovered/Resolved - ),<BR><BR>Vaccination site mass (n/a - Recovering/Resolving - ),<BR><BR>Vaccination site swelling (n/a - Recovering/Resolving - );VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Prophylaxis - Unknown - [n/a - n/a - n/a]);PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (C - Prophylaxis - Unknown - [n/a - n/a - n/a]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - Prophylaxis - Unknown - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010236583&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010242417;Spontaneous;2021-10-06 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Infantile spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Seizure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010242417&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010244302;Spontaneous;2021-10-06 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Juvenile idiopathic arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - 3{DF} - n/a]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - n/a - n/a - [n/a - 3{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010244302&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010215589;Spontaneous;2021-10-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Diarrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Hypertransaminasaemia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Liver disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Dose not changed - [n/a - 1{DF} - Intramuscular]),<BR><BR>ROTATEQ ORAL SOLUTION ROTAVIRUS VACCINE (LIVE) [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS] (S - Immunisation - Dose not changed - [n/a - 1{DF} - Oral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010215589&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010217989;Spontaneous;2021-10-05 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Neonate (Preterm and Term newborns);No;Male;Apathy (n/a - Fatal - Results in Death),<BR><BR>High-pitched crying (n/a - Fatal - Results in Death),<BR><BR>Pallor (n/a - Fatal - Results in Death),<BR><BR>Somnolence (n/a - Fatal - Results in Death);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - n/a]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010217989&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010220363;Spontaneous;2021-10-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Eye disorder (n/a - Unknown - ),<BR><BR>Haematoma (n/a - Unknown - ),<BR><BR>Movement disorder (n/a - Unknown - ),<BR><BR>Thrombosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010220363&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010220947;Spontaneous;2021-10-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Chapped lips (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Conjunctivitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Kawasaki's disease (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Lymphadenitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Otitis media (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pharyngeal erythema (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pharyngeal swelling (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Plantar erythema (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Rash (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Rash macular (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>INFANRIX HEXA POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010220947&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010203510;Spontaneous;2021-10-04 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apnoea (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Breath sounds abnormal (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Erythrosis (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hyporesponsive to stimuli (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010203510&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010203511;Spontaneous;2021-10-04 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Crying (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Syncope (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Dose not changed - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010203511&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010208307;Spontaneous;2021-10-04 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Lethargy (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010208307&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010210302;Spontaneous;2021-10-04 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Constipation (n/a - Unknown - Life Threatening),<BR><BR>Meningism (n/a - Not Recovered/Not Resolved - Life Threatening),<BR><BR>Opisthotonus (n/a - Not Recovered/Not Resolved - Life Threatening);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010210302&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010198921;Spontaneous;2021-10-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010198921&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010201125;Spontaneous;2021-10-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Inability to crawl (3d - Recovered/Resolved - Other Medically Important Condition);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - n/a - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010201125&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010193041;Spontaneous;2021-10-01 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Balance disorder (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Coordination abnormal (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Fall (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Inability to crawl (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Movement disorder (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Speech disorder developmental (n/a - Recovering/Resolving - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010193041&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010193979;Spontaneous;2021-10-01 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;Not Specified;Not Specified;No;Female;Communication disorder (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition),<BR><BR>Developmental delay (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - Parenteral]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Parenteral]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010193979&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010195955;Spontaneous;2021-10-01 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Labelled drug-drug interaction medication error (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Rash erythematous (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (I - Prophylaxis - Not applicable - [n/a - n/a - Unknown])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010195955&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010173157;Spontaneous;2021-09-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Infantile spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010173157&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010176443;Spontaneous;2021-09-30 00:00:00;Non Healthcare Professional;European Economic Area;Not available;18-64 Years;Not Specified;No;Male;Infection susceptibility increased (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Neurodermatitis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Pneumonitis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - 1{DF} - n/a]),<BR><BR>[MEASLES VACCINE (LIVE), RUBELLA VACCINE (LIVE), MUMPS VACCINE (LIVE)] (S - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[VARICELLA VIRUS OKA STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - n/a - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010176443&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010176636;Spontaneous;2021-09-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Cyanosis (5min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (5min - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - 2{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010176636&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010177287;Spontaneous;2021-09-30 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Anaphylactic reaction (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Incorrect route of product administration (n/a - Unknown - );BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010177287&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010178780;Spontaneous;2021-09-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Gait disturbance (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Seizure (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010178780&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010180144;Spontaneous;2021-09-30 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Decreased interest (2d - Recovered/Resolved - ),<BR><BR>Dyspnoea (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Gait inability (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Inability to crawl (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Irritability (n/a - Not Recovered/Not Resolved - ),<BR><BR>Listless (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - ),<BR><BR>Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010180144&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010157815;Spontaneous;2021-09-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (3d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Haemophilus influenzae type b immunisation - n/a - [n/a - 1{DF} - Intramuscular]),<BR><BR>NIMENRIX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Meningococcal immunisation - n/a - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010157815&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010160077;Spontaneous;2021-09-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (3d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010160077&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010168570;Spontaneous;2021-09-29 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Infant;No;Female;Meningitis haemophilus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vaccination failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [56d - 2{DF} - Subcutaneous]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010168570&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010149241;Spontaneous;2021-09-28 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypotonic-hyporesponsive episode (2min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010149241&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010149440;Spontaneous;2021-09-28 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Behaviour disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Crying (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Dysbiosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Malabsorption (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010149440&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010137067;Spontaneous;2021-09-27 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Female;Asthenia (n/a - Unknown - ),<BR><BR>Chills (n/a - Unknown - ),<BR><BR>Decreased appetite (n/a - Unknown - ),<BR><BR>Fatigue (n/a - Unknown - ),<BR><BR>Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010137067&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010140222;Spontaneous;2021-09-27 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Extensive swelling of vaccinated limb (n/a - Unknown - Other Medically Important Condition),<BR><BR>Joint swelling (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010140222&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010141764;Spontaneous;2021-09-27 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Autism spectrum disorder (n/a - Unknown - Other Medically Important Condition),<BR><BR>Behaviour disorder (n/a - Unknown - Other Medically Important Condition),<BR><BR>Extra dose administered (n/a - Unknown - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010141764&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010131424;Spontaneous;2021-09-25 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Clonus (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Flushing (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hyperaesthesia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypertonia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Opisthotonus (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Salivary hypersecretion (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Unresponsive to stimuli (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010131424&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010118562;Spontaneous;2021-09-24 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Asthma (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Vomiting projectile (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010118562&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010118568;Spontaneous;2021-09-24 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Not Specified;Fibrous dysplasia of bone (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Language disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Testicular microlithiasis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular]),<BR><BR>M-M-RVAXPRO POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION [MEASLES VIRUS ENDERS' EDMONSTON STRAIN (LIVE, ATTENUATED), MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010118568&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010129383;Spontaneous;2021-09-24 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Crying (20min - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Erythromelalgia (20min - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Irritability (20min - Recovered/Resolved - Other Medically Important Condition);PREVENAR 13 SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular]),<BR><BR>ROTARIX ORAL SUSPENSION IN PRE-FILLED ORAL APPLICATOR [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010129383&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010129872;Spontaneous;2021-09-24 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypotonic-hyporesponsive episode (2min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010129872&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010109452;Spontaneous;2021-09-23 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Irritability (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010109452&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010090436;Spontaneous;2021-09-22 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Coronary artery aneurysm (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Kawasaki's disease (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010090436&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010079932;Spontaneous;2021-09-21 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Male;Epilepsy (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Febrile convulsion (n/a - Recovering/Resolving - Other Medically Important Condition);[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010079932&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010083684;Spontaneous;2021-09-21 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Acute lymphocytic leukaemia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Bordetella test negative (n/a - Unknown - ),<BR><BR>Hepatitis B surface antigen negative (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010083684&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010084599;Spontaneous;2021-09-21 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Loss of consciousness (15min - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pallor (n/a - Recovered/Resolved - ),<BR><BR>Sensory loss (n/a - Recovered/Resolved - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010084599&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010084922;Spontaneous;2021-09-21 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Haematemesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010084922&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010064165;Spontaneous;2021-09-20 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Infant;No;Female;Crying (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Flatulence (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Haematochezia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Intussusception (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Restlessness (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010064165&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010069230;Spontaneous;2021-09-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Presyncope (10min - Recovered/Resolved - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010069230&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010033365;Spontaneous;2021-09-17 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Abdominal pain upper (n/a - Unknown - ),<BR><BR>Autoimmune colitis (n/a - Unknown - Other Medically Important Condition),<BR><BR>Crying (n/a - Unknown - ),<BR><BR>Diarrhoea (n/a - Unknown - ),<BR><BR>Food refusal (n/a - Unknown - ),<BR><BR>Hepatitis (n/a - Unknown - Other Medically Important Condition),<BR><BR>Insomnia (n/a - Recovered/Resolved - ),<BR><BR>Regurgitation (n/a - Unknown - ),<BR><BR>Screaming (n/a - Recovered/Resolved - ),<BR><BR>Vomiting (n/a - Recovered/Resolved - ),<BR><BR>Weight decreased (n/a - Unknown - );HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010033365&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010034858;Spontaneous;2021-09-17 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Apparent life threatening event (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Resuscitation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010034858&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010036833;Spontaneous;2021-09-17 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Female;Neoplasm skin (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Rhabdoid tumour (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Swelling (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Vaginal haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010036833&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010038318;Spontaneous;2021-09-17 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Chills (n/a - Unknown - Life Threatening),<BR><BR>Decreased interest (n/a - Unknown - Life Threatening),<BR><BR>Food refusal (n/a - Unknown - Life Threatening),<BR><BR>Irritability (n/a - Unknown - Life Threatening),<BR><BR>Pyrexia (n/a - Unknown - Life Threatening),<BR><BR>Restlessness (n/a - Unknown - Life Threatening),<BR><BR>Screaming (2d - Recovered/Resolved - Life Threatening),<BR><BR>Somnolence (n/a - Unknown - Life Threatening);[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010038318&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010018723;Spontaneous;2021-09-16 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Generalised tonic-clonic seizure (28d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - 2{DF} - n/a - More in ICSR])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010018723&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010020219;Spontaneous;2021-09-16 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Diarrhoea (22d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (22d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010020219&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010021188;Spontaneous;2021-09-16 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010021188&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010023146;Spontaneous;2021-09-16 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Female;Erysipelas (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Movement disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010023146&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010023448;Spontaneous;2021-09-16 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Haematemesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Infantile vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);ROTATEQ [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)] (S - Immunisation - Not applicable - [n/a - n/a - n/a]),<BR><BR>VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Immunisation - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL CONJUGATE VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010023448&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010024327;Spontaneous;2021-09-16 00:00:00;Healthcare Professional;European Economic Area;Not available;Not Specified;Child;No;Not Specified;Cyanosis (n/a - Recovered/Resolved - ),<BR><BR>Pyrexia (n/a - Recovered/Resolved - ),<BR><BR>Rash erythematous (n/a - Recovered/Resolved - ),<BR><BR>Skin discolouration (n/a - Recovered/Resolved - ),<BR><BR>Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010024327&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010024835;Spontaneous;2021-09-16 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Gastrooesophageal reflux disease (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonic-hyporesponsive episode (10min - Recovered/Resolved - Caused/Prolonged Hospitalisation);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [1d - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010024835&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010025411;Spontaneous;2021-09-16 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Infant;No;Female;Vaccination site abscess (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010025411&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010003901;Spontaneous;2021-09-15 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Cerebral palsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Coma (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Oxygen saturation decreased (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010003901&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010005700;Spontaneous;2021-09-15 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010005700&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010005702;Spontaneous;2021-09-15 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Generalised tonic-clonic seizure (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010005702&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010006185;Spontaneous;2021-09-15 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Seizure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010006185&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010007349;Spontaneous;2021-09-15 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Adult;No;Male;Febrile convulsion (5min - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]),<BR><BR>[ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, ALGELDRATE, NEISSERIA MENINGITIDIS GROUP C, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, TETANUS TOXOID, ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, ALUMINIUM, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, N. MENINGITIDIS GROUP C POLYSACCHARIDE, ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010007349&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010013177;Spontaneous;2021-09-15 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Anal abscess (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Bronchitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010013177&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10010013188;Spontaneous;2021-09-15 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Female;Hepatitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010013188&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009987866;Spontaneous;2021-09-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (3d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009987866&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009990670;Spontaneous;2021-09-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Vaccination site abscess (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009990670&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009990772;Spontaneous;2021-09-14 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Rash (n/a - Recovering/Resolving - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009990772&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009990797;Spontaneous;2021-09-14 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Bronchitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Cardiac murmur (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Crying (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Gastroenteritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009990797&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009993345;Spontaneous;2021-09-14 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Autism spectrum disorder (n/a - Unknown - Other Medically Important Condition),<BR><BR>Brain injury (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009993345&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009993658;Spontaneous;2021-09-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009993658&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009993664;Spontaneous;2021-09-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Intussusception (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]),<BR><BR>ROTARIX ORAL ROTAVIRUS VACCINE (LIVE, ATTENUATED) [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009993664&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009993672;Spontaneous;2021-09-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - n/a]),<BR><BR>[ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, ALGELDRATE, NEISSERIA MENINGITIDIS GROUP C, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, TETANUS TOXOID, ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, ALUMINIUM, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, N. MENINGITIDIS GROUP C POLYSACCHARIDE, ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009993672&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009978771;Spontaneous;2021-09-13 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypertonia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition),<BR><BR>Hyporesponsive to stimuli (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition),<BR><BR>Hypotonia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition),<BR><BR>Infantile colic (7d - Recovering/Resolving - Life Threatening, Other Medically Important Condition),<BR><BR>Infantile spitting up (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition),<BR><BR>Muscular weakness (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition),<BR><BR>Pallor (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition),<BR><BR>Posture abnormal (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition),<BR><BR>Somnolence (24h - Recovering/Resolving - Life Threatening, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009978771&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009980510;Spontaneous;2021-09-13 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;Not Specified;Infant;No;Male;Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - Oral]);PALIVIZUMAB [PALIVIZUMAB] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>[ACICLOVIR, ACICLOVIR SODIUM] (C - Product used for unknown indication - Unknown - [2d - n/a - Unknown]),<BR><BR>[CEFALEXIN, CEFALEXIN MONOHYDRATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>[GENTAMICIN, GENTAMICIN SULFATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>[MYCOBACTERIUM BOVIS, DANISH STRAIN 1331] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>[PHENOBARBITAL, PHENOBARBITAL SODIUM] (C - Product used for unknown indication - Unknown - [2d - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009980510&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009980914;Spontaneous;2021-09-13 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Infant;No;Female;Hypotonic-hyporesponsive episode (1min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009980914&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009960783;Spontaneous;2021-09-10 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Neonate (Preterm and Term newborns);No;Male;Immune thrombocytopenia (5d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009960783&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009960810;Spontaneous;2021-09-10 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Neonate (Preterm and Term newborns);No;Male;Altered state of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - 2{DF} - n/a]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - n/a - n/a - [n/a - 2{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009960810&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009968307;Spontaneous;2021-09-10 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Seizure (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009968307&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009970136;Spontaneous;2021-09-10 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Erythema (0d - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Muscular weakness (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009970136&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009942859;Spontaneous;2021-09-09 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (3d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009942859&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009949117;Spontaneous;2021-09-09 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;External hydrocephalus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009949117&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009950942;Spontaneous;2021-09-09 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Seizure (2d - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Tic (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009950942&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009950962;Spontaneous;2021-09-09 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Infantile spasms (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - Oral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009950962&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009951191;Spontaneous;2021-09-09 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Muscle spasms (n/a - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009951191&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009930681;Spontaneous;2021-09-08 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Abnormal faeces (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Neutropenia (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Restlessness (n/a - Recovering/Resolving - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009930681&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009933129;Spontaneous;2021-09-08 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Areflexia (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Blindness (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Blindness cortical (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Cerebellar atrophy (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Constipation (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Dermoid cyst (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Developmental delay (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Dyskinesia (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Dysphagia (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Eczema (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Encephalopathy (n/a - Unknown - Other Medically Important Condition),<BR><BR>Epilepsy (n/a - Unknown - Other Medically Important Condition),<BR><BR>Eye movement disorder (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Head circumference abnormal (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Hyperacusis (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Hypertonia (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Hypotonia (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Kyphosis (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Learning disorder (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Metabolic disorder (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Microcephaly (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Middle insomnia (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Motor dysfunction (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Muscle spasticity (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Mydriasis (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Nystagmus (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Oral disorder (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Peripheral coldness (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Photophobia (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Physical disability (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Psychomotor skills impaired (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Quadriparesis (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Speech disorder developmental (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Strabismus (n/a - Unknown - Disabling, Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown]);PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (C - Immunisation - Not applicable - [n/a - 1{DF} - Unknown]),<BR><BR>[DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALUMINIUM HYDROXIDE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALUMINIUM HYDROXIDE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, ALUMINIUM HYDROXIDE] (C - Immunisation - Not applicable - [n/a - 1{DF} - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009933129&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009934013;Spontaneous;2021-09-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Neonate (Preterm and Term newborns);No;Female;Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - 2{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009934013&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009936679;Spontaneous;2021-09-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Cerebral palsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Muscle spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Oxygen saturation decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009936679&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009938468;Spontaneous;2021-09-08 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Gastrooesophageal reflux disease (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonic-hyporesponsive episode (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009938468&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009902643;Spontaneous;2021-09-06 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Female;Alopecia (n/a - Recovered/Resolved - ),<BR><BR>Crying (1a - Recovered/Resolved - ),<BR><BR>Crying (n/a - Recovered/Resolved - ),<BR><BR>Eye haemorrhage (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyperpyrexia (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Insomnia (n/a - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular - More in ICSR]),<BR><BR>[MYCOBACTERIUM BOVIS, DANISH STRAIN 1331] (S - Prophylaxis - Not applicable - [1d - .1mL - Subcutaneous]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009902643&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009902799;Spontaneous;2021-09-06 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Neonate (Preterm and Term newborns);No;Male;Henoch-Schonlein purpura nephritis (68d - Recovered/Resolved - Caused/Prolonged Hospitalisation);VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Immunisation - n/a - [n/a - 2{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009902799&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009881382;Spontaneous;2021-09-03 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009881382&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009881383;Spontaneous;2021-09-03 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009881383&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009882525;Spontaneous;2021-09-03 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Febrile convulsion (3min - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - 2{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009882525&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009865349;Spontaneous;2021-09-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009865349&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009870972;Spontaneous;2021-09-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Epilepsy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Muscle spasms (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Muscle twitching (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])...;INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009870972&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009874043;Spontaneous;2021-09-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Atonic seizures (1min - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009874043&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009850896;Spontaneous;2021-09-01 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009850896&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009858758;Spontaneous;2021-09-01 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Acidosis (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Gastroenteritis (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]),<BR><BR>[CORYNEBACTERIUM DIPHTHERIAE, NEISSERIA MENINGITIDIS, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, ALUMINIUM HYDROXIDE] (S - n/a - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009858758&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009859045;Spontaneous;2021-09-01 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Urticaria (30min - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - n/a]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009859045&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009831003;Spontaneous;2021-08-30 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Seizure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009831003&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009831005;Spontaneous;2021-08-30 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Crying (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Emotional distress (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Insomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Panic reaction (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Vaccination site pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Vaccination site swelling (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Parenteral]);[PARACETAMOL] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009831005&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009834514;Spontaneous;2021-08-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Lethargy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009834514&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009806037;Spontaneous;2021-08-27 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Autism spectrum disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Infantile apnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - 1{DF} - n/a]),<BR><BR>[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - Immunisation - n/a - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009806037&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009813546;Spontaneous;2021-08-27 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Crying (n/a - Unknown - ),<BR><BR>Decreased appetite (n/a - Unknown - ),<BR><BR>Hypertonia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Insomnia (n/a - Unknown - ),<BR><BR>Irritability (n/a - Unknown - Other Medically Important Condition),<BR><BR>Opisthotonus (n/a - Unknown - Other Medically Important Condition),<BR><BR>Psychomotor skills impaired (n/a - Unknown - ),<BR><BR>Pyrexia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Seizure (n/a - Unknown - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009813546&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009813969;Spontaneous;2021-08-27 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Crying (n/a - Unknown - ),<BR><BR>Decreased appetite (n/a - Unknown - ),<BR><BR>Hypertonia (n/a - Unknown - ),<BR><BR>Insomnia (n/a - Unknown - ),<BR><BR>Irritability (n/a - Unknown - ),<BR><BR>Opisthotonus (n/a - Unknown - ),<BR><BR>Psychomotor skills impaired (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Seizure (n/a - Unknown - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1min - 1{DF} - Intramuscular - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009813969&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009815890;Spontaneous;2021-08-27 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Infant;No;Male;Meningitis haemophilus (n/a - Recovered/Resolved - Life Threatening),<BR><BR>Vaccination failure (n/a - Recovered/Resolved - Life Threatening);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [60d - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009815890&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009794819;Spontaneous;2021-08-26 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apnoeic attack (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Bradycardia (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Neonatal hypoxia (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009794819&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009797038;Spontaneous;2021-08-26 00:00:00;Healthcare Professional;European Economic Area;Not available;12-17 Years;Not Specified;No;Male;Chills (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Eating disorder (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Fatigue (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Hyperpyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Metabolic disorder (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009797038&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009787225;Spontaneous;2021-08-25 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Dermatitis atopic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Food allergy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009787225&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009765524;Spontaneous;2021-08-24 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Apnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Muscle rigidity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);PREVENAR 13 SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[PARACETAMOL] (C - n/a - n/a - [n/a - 3[drp] - Oral]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009765524&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009768309;Spontaneous;2021-08-24 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;18-64 Years;Not Specified;No;Male;Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Lymphadenopathy (16d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Malaise (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Swelling (n/a - Recovered/Resolved - Other Medically Important Condition);COVID-19 MRNA VACCINE MODERNA (CX-024414) [COVID-19 MRNA VACCINE MODERNA (CX-024414)] (S - COVID-19 immunisation - Unknown - [n/a - 1{DF} - Unknown]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Unknown - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009768309&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009768510;Spontaneous;2021-08-24 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Pyrexia (2d - Recovered/Resolved - ),<BR><BR>Rash erythematous (1d - Recovered/Resolved - ),<BR><BR>Rash maculo-papular (1d - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009768510&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009756685;Spontaneous;2021-08-23 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Female;Anaphylactic reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Febrile convulsion (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Injection site erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Injection site pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Screaming (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Somnolence (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Unknown])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009756685&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009760052;Spontaneous;2021-08-23 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Haematochezia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Milk allergy (n/a - Not Recovered/Not Resolved - );HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL CONJUGATE VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009760052&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009741803;Spontaneous;2021-08-20 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Eczema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009741803&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009741804;Spontaneous;2021-08-20 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009741804&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009745413;Spontaneous;2021-08-20 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Apathy (2d - Recovered/Resolved - ),<BR><BR>Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vomiting (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009745413&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009729815;Spontaneous;2021-08-19 00:00:00;Healthcare Professional;European Economic Area;"Sarcina D, Giovannini M, Oranges T, Barni S, Pedaci FA, Liccioli G, et al.. Case Report and Review of the Literature: Bullous Skin Eruption After the Booster-Dose of Influenza Vaccine in a Pediatric Patient With Polymorphic Maculopapular Cutaneous Mastocytosis.. Frontiers in Immunology.. 2021;12(688364):doi:10.3389/fimmu.2021.688364.";Not Specified;Infant;No;Female;Dermatitis bullous (n/a - Unknown - Other Medically Important Condition),<BR><BR>Irritability (n/a - Unknown - ),<BR><BR>Pruritus (n/a - Unknown - ),<BR><BR>Pyrexia (2d - Recovered/Resolved - ),<BR><BR>Pyrexia (n/a - Recovered/Resolved - ),<BR><BR>Pyrexia (n/a - Unknown - ),<BR><BR>Skin lesion (n/a - Recovered/Resolved - );[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[INFLUENZA QUADRIVALENT VACCINE (RDNA)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[MENINGOCOCCAL GROUP B VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[MENINGOCOCCAL GROUP C CONJUGATE VACCINE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);[ROTAVIRUS VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009729815&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009735028;Spontaneous;2021-08-19 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apnoea (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Urticaria (48h - Recovered/Resolved - );BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[HEPATITIS B VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009735028&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009718675;Spontaneous;2021-08-18 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Dyskinesia (n/a - Recovering/Resolving - ),<BR><BR>Dyskinesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Gaze palsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Grimacing (n/a - Recovering/Resolving - ),<BR><BR>Infantile back arching (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009718675&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009723788;Spontaneous;2021-08-18 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Diarrhoea haemorrhagic (2d - Recovered/Resolved - Other Medically Important Condition);VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Prophylaxis - Unknown - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009723788&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009703166;Spontaneous;2021-08-17 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Depressed level of consciousness (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009703166&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009703886;Spontaneous;2021-08-17 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - n/a - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009703886&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009705414;Spontaneous;2021-08-17 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Lymph node pain (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Lymphadenopathy (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009705414&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009687139;Spontaneous;2021-08-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Petechiae (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009687139&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009676137;Spontaneous;2021-08-13 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperresponsive to stimuli (20min - Recovered/Resolved - ),<BR><BR>Hypotonic-hyporesponsive episode (20min - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009676137&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009677045;Spontaneous;2021-08-13 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Drug ineffective (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Floppy infant (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Incorrect route of product administration (n/a - Unknown - ),<BR><BR>Pallor (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Sepsis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Underdose (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])...;INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (C - Ill-defined disorder - Not applicable - [n/a - n/a - Unknown]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - Ill-defined disorder - Not applicable - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009677045&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009661292;Spontaneous;2021-08-12 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009661292&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009667466;Spontaneous;2021-08-12 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Not Specified;No;Female;Febrile convulsion (5min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);VAXELIS SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009667466&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009670319;Spontaneous;2021-08-12 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Myoclonus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009670319&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009650134;Spontaneous;2021-08-11 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009650134&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009654400;Spontaneous;2021-08-11 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;C-reactive protein abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009654400&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009656807;Spontaneous;2021-08-11 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Male;Musculoskeletal disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009656807&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009639393;Spontaneous;2021-08-10 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Pyrexia (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Thrombocytopenia (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009639393&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009644573;Spontaneous;2021-08-10 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Crying (n/a - Unknown - ),<BR><BR>Erythema of eyelid (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Eyelid oedema (20h - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Lip oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Oedema mouth (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Rash (n/a - Unknown - ),<BR><BR>Rash maculo-papular (20h - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Tongue disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Urticaria (20h - Recovered/Resolved - Caused/Prolonged Hospitalisation);MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a]),<BR><BR>[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>ROTATEQ [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009644573&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009609174;Spontaneous;2021-08-06 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - n/a - Parenteral])...;BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009609174&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009616858;Spontaneous;2021-08-06 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Hemiparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009616858&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009619980;Spontaneous;2021-08-06 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Pyrexia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Rash erythematous (1d - Recovered/Resolved - );BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (I - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...;BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009619980&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009598013;Spontaneous;2021-08-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Crying (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Lividity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Oedema peripheral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Petechiae (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009598013&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009598240;Spontaneous;2021-08-05 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Febrile convulsion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Laryngitis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Upper respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009598240&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009600271;Spontaneous;2021-08-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009600271&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009605223;Spontaneous;2021-08-05 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Crying (n/a - Unknown - ),<BR><BR>Human herpesvirus 6 infection (n/a - Fatal - Results in Death),<BR><BR>Restlessness (n/a - Unknown - ),<BR><BR>Sudden infant death syndrome (n/a - Fatal - Results in Death, Other Medically Important Condition),<BR><BR>Unresponsive to stimuli (n/a - Unknown - Other Medically Important Condition);[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>[PNEUMOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>[POLIOMYELITIS VACCINE (ORAL)] (S - Prophylaxis - Not applicable - [n/a - n/a - Oral]),<BR><BR>[ROTAVIRUS VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - Oral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009605223&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009584637;Spontaneous;2021-08-04 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Abnormal behaviour (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Crying (n/a - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - n/a - n/a - [n/a - 1.5mL - Oral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009584637&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009586096;Spontaneous;2021-08-04 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Epilepsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Melanocytic naevus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009586096&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009588371;Spontaneous;2021-08-04 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Eczema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Eczema (n/a - Unknown - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Immunisation - Not applicable - [1d - n/a - n/a]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - n/a - n/a - More in ICSR])...;[CHLORPHENAMINE MALEATE] (C - Food allergy - Unknown - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009588371&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009590244;Spontaneous;2021-08-04 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Infant;No;Male;Immune thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009590244&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009590245;Spontaneous;2021-08-04 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Neonate (Preterm and Term newborns);No;Male;Immune thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009590245&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009593328;Spontaneous;2021-08-04 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Drug ineffective (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Floppy infant (2880min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pallor (2880min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Sepsis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])...;INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009593328&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009570315;Spontaneous;2021-08-03 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Febrile convulsion (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009570315&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009570378;Spontaneous;2021-08-03 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009570378&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009574906;Spontaneous;2021-08-03 00:00:00;Healthcare Professional;European Economic Area;Not available;12-17 Years;Not Specified;No;Female;Body temperature increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009574906&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009578668;Spontaneous;2021-08-03 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;Yes;Female;Sudden infant death syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [n/a - n/a - Oral]),<BR><BR>[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>[PNEUMOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>[POLIOMYELITIS VACCINE (ORAL)] (S - Prophylaxis - Not applicable - [n/a - n/a - Oral]);[MYCOBACTERIUM BOVIS, DANISH STRAIN 1331] (C - Prophylaxis - Not applicable - [n/a - n/a - Intradermal]),<BR><BR>[POLIOMYELITIS VACCINE (ORAL)] (C - Prophylaxis - Not applicable - [n/a - n/a - Oral]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009578668&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009559777;Spontaneous;2021-08-02 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Apathy (27d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Syncope (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009559777&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009568174;Spontaneous;2021-08-02 00:00:00;Healthcare Professional;Non European Economic Area;"Almeshary MZ, Alanazi SA, Almoosa KM, Bassrawi RK.. Kawasaki disease in an infant after administration of hexavalent vaccine.. Saudi Medical Journal. 2021;42(7):790-792. doi:10.15537/smj.2021.42.7.20210061";2 Months - 2 Years;Not Specified;No;Male;Conjunctivitis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Coronary artery dilatation (n/a - Unknown - ),<BR><BR>Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Kawasaki's disease (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Lip erythema (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Rash maculo-papular (n/a - Unknown - Caused/Prolonged Hospitalisation);[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009568174&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009568849;Spontaneous;2021-08-02 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyperthermia (n/a - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009568849&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009539670;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009539670&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009539692;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (5d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009539692&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009539694;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Cough (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009539694&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009539697;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]),<BR><BR>NIMENRIX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009539697&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009539702;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular]),<BR><BR>NIMENRIX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009539702&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009539705;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Cough (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009539705&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009539714;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>NIMENRIX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009539714&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009539732;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Seizure (0d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009539732&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009539743;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009539743&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009539761;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (0d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009539761&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009541112;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;Non European Economic Area;"Deng L, Ma A, Wood N, Ardern-Holmes S. Vaccination management in an asymptomatic child with a novel SCN1A variant and family history of status epilepticus following vaccination: A case report on a potential new direction in personalised medicine. Seizure. 2020;78:49-52";2 Months - 2 Years;Not Specified;No;Male;Brain death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Brain herniation (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Brain oedema (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Cardio-respiratory arrest (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Diabetes insipidus (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Enterovirus infection (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Febrile convulsion (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Hyperglycaemia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Hypertension (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Hyperthermia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Hypoxic-ischaemic encephalopathy (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pulmonary oedema (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Rhinorrhoea (n/a - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Staring (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Status epilepticus (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Tardive dyskinesia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Tonic clonic movements (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Unresponsive to stimuli (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS [RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - n/a - Not applicable - [n/a - n/a - n/a]),<BR><BR>[DIPHTHERIA, TETANUS, PERTUSSIS AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED)] (S - n/a - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE] (S - n/a - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT] (S - Prophylaxis - Not applicable - [n/a - n/a - Oral]),<BR><BR>[ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT] (S - n/a - Not applicable - [n/a - n/a - Oral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009541112&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009542272;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Not Specified;No;Not Specified;Hypotonic-hyporesponsive episode (1h - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009542272&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009551439;Spontaneous;2021-07-30 00:00:00;Healthcare Professional;Non European Economic Area;Not available;Not Specified;Infant;No;Not Specified;Haematochezia (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Mucous stools (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular]),<BR><BR>ROTATEQ [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)] (S - Prophylaxis - Not applicable - [n/a - 2mL - Oral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009551439&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009525918;Spontaneous;2021-07-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Diarrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Hyperpyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Kawasaki's disease (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009525918&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009525933;Spontaneous;2021-07-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Restlessness (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]),<BR><BR>NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009525933&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009525935;Spontaneous;2021-07-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vomiting (2d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009525935&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009525948;Spontaneous;2021-07-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Febrile convulsion (14d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyperpyrexia (14d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]),<BR><BR>NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009525948&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009525957;Spontaneous;2021-07-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Crying (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009525957&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009525973;Spontaneous;2021-07-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]),<BR><BR>NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009525973&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009501131;Spontaneous;2021-07-28 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Encephalitis (n/a - Recovered/Resolved - Life Threatening);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009501131&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009513606;Spontaneous;2021-07-28 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;0-1 Month;Not Specified;No;Female;Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Respiratory distress (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - .5mL - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009513606&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009513628;Spontaneous;2021-07-28 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Autism spectrum disorder (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009513628&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009521184;Spontaneous;2021-07-28 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Male;Disturbance in attention (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009521184&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009523748;Spontaneous;2021-07-28 00:00:00;Healthcare Professional;European Economic Area;Not available;Not Specified;Not Specified;No;Male;Hypoxic-ischaemic encephalopathy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Sepsis (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Sudden infant death syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - 2{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009523748&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009524183;Spontaneous;2021-07-28 00:00:00;Non Healthcare Professional;European Economic Area;Not available;0-1 Month;Infant;No;Female;Abdominal pain upper (1496d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Eczema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Haematochezia (4d - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (2d - Recovering/Resolving - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009524183&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009488409;Spontaneous;2021-07-27 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Astigmatism (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Autism spectrum disorder (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Conjunctivitis (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Constipation (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Dermatitis (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Oral herpes (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Urticaria (n/a - Not Recovered/Not Resolved - Disabling);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - Unknown - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009488409&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009492482;Spontaneous;2021-07-27 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Crying (n/a - Unknown - ),<BR><BR>Discomfort (n/a - Unknown - ),<BR><BR>Gait disturbance (n/a - Unknown - ),<BR><BR>Hyperaesthesia (n/a - Unknown - ),<BR><BR>Hypotonic-hyporesponsive episode (n/a - Unknown - Other Medically Important Condition),<BR><BR>Malaise (n/a - Unknown - ),<BR><BR>Pallor (n/a - Unknown - ),<BR><BR>Screaming (n/a - Unknown - ),<BR><BR>Unresponsive to stimuli (n/a - Unknown - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009492482&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009494374;Spontaneous;2021-07-27 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Infant irritability (n/a - Unknown - ),<BR><BR>Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Rash erythematous (1d - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - n/a - Parenteral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009494374&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009484215;Spontaneous;2021-07-26 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Infant;No;Female;Angioedema (n/a - Recovering/Resolving - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009484215&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009486323;Spontaneous;2021-07-26 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Sudden infant death syndrome (n/a - Fatal - Results in Death);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009486323&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009476013;Spontaneous;2021-07-25 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Vaccination site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009476013&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009466433;Spontaneous;2021-07-23 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Dysuria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Feeding disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - ),<BR><BR>Restlessness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Prophylaxis - Unknown - [n/a - 1{DF} - n/a - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009466433&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009466738;Spontaneous;2021-07-23 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Erythema (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Peripheral swelling (n/a - Recovering/Resolving - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Parenteral]);[PARACETAMOL] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009466738&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009452241;Spontaneous;2021-07-22 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009452241&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009440000;Spontaneous;2021-07-21 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Crying (6h - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009440000&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009416736;Spontaneous;2021-07-20 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Aggression (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Crying (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Decreased appetite (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Irritability (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Pyrexia (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Skin reaction (n/a - Not Recovered/Not Resolved - Disabling);VAXELIS SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - n/a - n/a - [n/a - n/a - n/a]);PROQUAD [MEASLES VIRUS ENDERS' EDMONSTON STRAIN (LIVE, ATTENUATED), MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009416736&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009418319;Spontaneous;2021-07-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (1d - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009418319&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009420402;Spontaneous;2021-07-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Petit mal epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition);VAXELIS SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009420402&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009421966;Spontaneous;2021-07-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Intussusception (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009421966&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009422356;Spontaneous;2021-07-20 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Apathy (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Crying (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Microcephaly (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Psychomotor retardation (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Quadriplegia (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Strabismus (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Unresponsive to stimuli (n/a - Not Recovered/Not Resolved - Disabling);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009422356&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009426780;Spontaneous;2021-07-20 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Raynaud's phenomenon (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Strabismus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED)] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009426780&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009429148;Spontaneous;2021-07-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Petit mal epilepsy (2d - Recovered/Resolved - Other Medically Important Condition);PREVENAR 13 SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009429148&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009429296;Spontaneous;2021-07-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyperpyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);PREVENAR 13 SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE] (S - Pneumococcal immunisation - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009429296&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009429344;Spontaneous;2021-07-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009429344&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009401324;Spontaneous;2021-07-19 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Concussion (1d - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Syncope (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Wrong product administered (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009401324&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009394752;Spontaneous;2021-07-17 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Angioedema (n/a - Recovering/Resolving - Life Threatening),<BR><BR>Dyspnoea (n/a - Recovering/Resolving - Life Threatening),<BR><BR>Rash (n/a - Recovering/Resolving - Life Threatening),<BR><BR>Rash pruritic (n/a - Recovering/Resolving - Life Threatening);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009394752&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009386877;Spontaneous;2021-07-16 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Febrile convulsion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009386877&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009388478;Spontaneous;2021-07-16 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Anxiety (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Crying (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009388478&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009364812;Spontaneous;2021-07-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Presyncope (0d - Recovered/Resolved - Life Threatening),<BR><BR>Somnolence (0d - Recovered/Resolved - Life Threatening);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009364812&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009366911;Spontaneous;2021-07-14 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Bradykinesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Brain injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition),<BR><BR>Crying (n/a - Unknown - ),<BR><BR>Developmental delay (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Dyskinesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Dystonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition),<BR><BR>Encephalitis autoimmune (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition),<BR><BR>Intellectual disability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition),<BR><BR>Mental impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition),<BR><BR>Motor developmental delay (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Motor dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Muscle injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Neurodegenerative disorder (n/a - Unknown - Other Medically Important Condition),<BR><BR>Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009366911&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009367803;Spontaneous;2021-07-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Anxiety (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>C-reactive protein increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009367803&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009367898;Spontaneous;2021-07-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009367898&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009367903;Spontaneous;2021-07-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Apnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009367903&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009368147;Spontaneous;2021-07-14 00:00:00;Healthcare Professional;European Economic Area;Not available;Not Specified;Not Specified;No;Not Specified;Chills (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009368147&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009368178;Spontaneous;2021-07-14 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Not Specified;No;Male;Crying (n/a - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - n/a - n/a - [n/a - 1.5mL - Oral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009368178&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009346319;Spontaneous;2021-07-13 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;Not Specified;Not Specified;No;Not Specified;Axillary pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Chest pain (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pain in extremity (30d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Vaccination site pain (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - n/a - [n/a - n/a - n/a]),<BR><BR>TOZINAMERAN [TOZINAMERAN] (S - COVID-19 immunisation - Not applicable - [1d - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009346319&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009346951;Spontaneous;2021-07-13 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Decreased appetite (3d - Recovered/Resolved - ),<BR><BR>Insomnia (3d - Recovered/Resolved - ),<BR><BR>Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Restlessness (3d - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009346951&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009349460;Spontaneous;2021-07-13 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009349460&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009350796;Spontaneous;2021-07-13 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Vaccination site erythema (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site induration (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site oedema (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site warmth (3d - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1min - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009350796&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009351981;Spontaneous;2021-07-13 00:00:00;Healthcare Professional;Non European Economic Area;"Deng L., Danchin M., Lewis G., Cheung A., Campbell J. A., Wadia U., et al.. Revaccination outcomes of children with vaccine proximate seizures. Vaccine. 2021;39:1565-1571. doi:https://doi.org/10.1016/j.vaccine.2021.02.016";2 Months - 2 Years;Not Specified;No;Not Specified;Severe myoclonic epilepsy of infancy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Status epilepticus (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);[DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR, COMPONENT) VACCINE (ADSORBED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]),<BR><BR>[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]),<BR><BR>[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]),<BR><BR>[MENINGOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]),<BR><BR>[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]),<BR><BR>[ROTAVIRUS VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009351981&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009353631;Spontaneous;2021-07-13 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Application site swelling (n/a - Unknown - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009353631&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009353655;Spontaneous;2021-07-13 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Sudden infant death syndrome (n/a - Fatal - Results in Death, Life Threatening, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009353655&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009354352;Spontaneous;2021-07-13 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Behaviour disorder (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Decreased activity (15d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Diarrhoea (13d - Recovered/Resolved - ),<BR><BR>Language disorder (10d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [5s - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009354352&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009357553;Spontaneous;2021-07-13 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Hypotonic-hyporesponsive episode (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - ),<BR><BR>Respiratory rate increased (n/a - Unknown - ),<BR><BR>Yawning (n/a - Unknown - );HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009357553&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009333870;Spontaneous;2021-07-12 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Anxiety (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Sleep disorder (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Unresponsive to stimuli (n/a - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009333870&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009336157;Spontaneous;2021-07-12 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Crying (n/a - Recovered/Resolved - ),<BR><BR>Puncture site oedema (14d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - ),<BR><BR>Restlessness (1d - Recovered/Resolved - ),<BR><BR>Vaccination site mass (n/a - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009336157&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009337185;Spontaneous;2021-07-12 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Vaccination site reaction (n/a - Recovering/Resolving - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009337185&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009342288;Spontaneous;2021-07-12 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;Yes;Female;Apnoea (n/a - Unknown - Other Medically Important Condition),<BR><BR>Asthenia (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Bradycardia (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Cardiac murmur (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Decreased appetite (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Diarrhoea (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Faeces discoloured (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Gastroenteritis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Hypoglycaemia (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Insomnia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Irregular breathing (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Irritability (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Meningitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Meningitis meningococcal (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Meningococcal bacteraemia (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Moaning (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Petechiae (n/a - Fatal - Results in Death),<BR><BR>Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Poor peripheral circulation (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Purpura (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Purpura fulminans (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Rash macular (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Sepsis (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Tachyarrhythmia (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Tachycardia (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Tympanic membrane hyperaemia (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation),<BR><BR>Waterhouse-Friderichsen syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - n/a]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [1d - n/a - n/a]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009342288&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009331717;Spontaneous;2021-07-11 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Balance disorder (7d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009331717&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009332190;Spontaneous;2021-07-11 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;C-reactive protein increased (n/a - Recovered/Resolved - ),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009332190&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009332192;Spontaneous;2021-07-11 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Crying (3h - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Decreased appetite (6h - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009332192&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009332680;Spontaneous;2021-07-11 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Febrile convulsion (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009332680&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009318723;Spontaneous;2021-07-09 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypertransaminasaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - n/a - n/a - [n/a - 1.5mL - Oral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009318723&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009322826;Spontaneous;2021-07-09 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypogammaglobulinaemia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Malaise (n/a - Unknown - ),<BR><BR>Nasal congestion (1mo - Recovered/Resolved - ),<BR><BR>Nasopharyngitis (1mo - Recovered/Resolved - ),<BR><BR>Neutropenia (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009322826&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009301429;Spontaneous;2021-07-08 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Apnoea (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Irregular breathing (n/a - Unknown - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009301429&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009303538;Spontaneous;2021-07-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Breath odour (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Rhinitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009303538&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009303951;Spontaneous;2021-07-08 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Neonate (Preterm and Term newborns);No;Female;Sudden infant death syndrome (50min - Fatal - Results in Death, Caused/Prolonged Hospitalisation);[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]),<BR><BR>[MYCOBACTERIUM BOVIS, DANISH STRAIN 1331] (S - Immunisation - n/a - [n/a - n/a - Intradermal]),<BR><BR>[PNEUMOCOCCAL CONJUGATE VACCINE] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]),<BR><BR>[POLIOMYELITIS VACCINE (ORAL)] (S - Immunisation - n/a - [n/a - n/a - Oral]),<BR><BR>[ROTAVIRUS VACCINE] (S - Immunisation - n/a - [n/a - n/a - Oral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009303951&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009310955;Spontaneous;2021-07-08 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Asthmatic crisis (n/a - Unknown - Other Medically Important Condition),<BR><BR>Oedema (n/a - Unknown - Other Medically Important Condition),<BR><BR>Unevaluable event (n/a - Unknown - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);[MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS (LIVE, ATTENUATED), RUBELLA VIRUS (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED)] (C - Immunisation - n/a - [n/a - n/a - Unknown]),<BR><BR>[N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, ALGELDRATE] (C - Immunisation - n/a - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009310955&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009292343;Spontaneous;2021-07-07 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Depressed level of consciousness (0d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypotonia (0d - Recovered/Resolved - ),<BR><BR>Hypotonic-hyporesponsive episode (0d - Recovered/Resolved - ),<BR><BR>Pallor (0d - Recovered/Resolved - ),<BR><BR>Presyncope (0d - Recovered/Resolved - ),<BR><BR>Vomiting (0d - Recovered/Resolved - );HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [n/a - n/a - Oral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009292343&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009296162;Spontaneous;2021-07-07 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Constipation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Decreased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009296162&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009274207;Spontaneous;2021-07-06 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Somnolence (86d - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009274207&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009281197;Spontaneous;2021-07-06 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Pyrexia (1d - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009281197&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009282353;Spontaneous;2021-07-06 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Male;Mobility decreased (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Neurodermatitis (1744d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009282353&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009258000;Spontaneous;2021-07-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Acute haemorrhagic oedema of infancy (n/a - Unknown - Other Medically Important Condition);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009258000&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009246717;Spontaneous;2021-07-03 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Crying (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Lymphadenitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Moaning (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Screaming (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009246717&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009236957;Spontaneous;2021-07-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Aggression (n/a - Unknown - Other Medically Important Condition),<BR><BR>Febrile convulsion (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Gaze palsy (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Irritability (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009236957&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009237302;Spontaneous;2021-07-02 00:00:00;Healthcare Professional;European Economic Area;Not available;Not Specified;Not Specified;No;Female;Extensive swelling of vaccinated limb (4d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyperaemia (4d - Recovered/Resolved - ),<BR><BR>Pyrexia (4d - Recovered/Resolved - ),<BR><BR>Vaccination site erythema (4d - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009237302&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009241731;Spontaneous;2021-07-02 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Febrile convulsion (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009241731&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009242968;Spontaneous;2021-07-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Sudden infant death syndrome (n/a - Fatal - Results in Death, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009242968&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009247107;Spontaneous;2021-07-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Anaphylactic reaction (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Injection site erythema (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Respiratory distress (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Urticaria (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);PREVENAR 13 SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE] (S - Prophylaxis - Drug withdrawn - [1d - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009247107&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009247932;Spontaneous;2021-07-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Acute haemorrhagic oedema of infancy (n/a - Unknown - Other Medically Important Condition);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - COVID-19 immunisation - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009247932&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009232102;Spontaneous;2021-07-01 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Cough (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Decreased appetite (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Rash (n/a - Recovering/Resolving - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009232102&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009209370;Spontaneous;2021-06-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Acute respiratory failure (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Altered state of consciousness (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Dyskinesia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Status epilepticus (45min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009209370&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009190332;Spontaneous;2021-06-29 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Dyspnoea (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Febrile convulsion (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Loss of consciousness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009190332&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009170734;Spontaneous;2021-06-28 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Asthenia (38d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Brain neoplasm malignant (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Decreased immune responsiveness (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Ear infection (38d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Ear infection (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Inflammation (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Malignant neoplasm removal (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Neonatal disorder (38d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Petit mal epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Poor feeding infant (38d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Sedation (38d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Somnolence (38d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Unresponsive to stimuli (38d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Urinary tract infection (38d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009170734&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009171701;Spontaneous;2021-06-28 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Blood creatine phosphokinase increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009171701&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009150249;Spontaneous;2021-06-25 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Injection site erythema (4d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Injection site oedema (4d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pain in extremity (n/a - Unknown - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009150249&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009134581;Spontaneous;2021-06-24 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Monoplegia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - n/a]);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009134581&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009136843;Spontaneous;2021-06-24 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Tonsillitis (n/a - Unknown - Other Medically Important Condition);[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009136843&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009114588;Spontaneous;2021-06-23 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009114588&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009115099;Spontaneous;2021-06-23 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;High-pitched crying (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - Parenteral]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009115099&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009117834;Spontaneous;2021-06-23 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Generalised tonic-clonic seizure (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009117834&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009119170;Spontaneous;2021-06-23 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Infant;No;Male;Vaccination complication (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009119170&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009096818;Spontaneous;2021-06-22 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009096818&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009103183;Spontaneous;2021-06-22 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Headache (n/a - Unknown - Other Medically Important Condition),<BR><BR>Injection site erythema (n/a - Unknown - ),<BR><BR>Loss of consciousness (0d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Puncture site pain (n/a - Unknown - ),<BR><BR>Speech disorder (n/a - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009103183&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009107581;Spontaneous;2021-06-22 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Apnoea (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - n/a]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [1d - n/a - n/a]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009107581&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009109296;Spontaneous;2021-06-22 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Atrial septal defect (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Chills (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Contusion (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Cough (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Crying (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Device related sepsis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Disseminated intravascular coagulation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Hypertonia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Hypokalaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Hypophosphataemia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Illness (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Klebsiella infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Meningococcal infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Meningococcal sepsis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Petechiae (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Rash (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Rash erythematous (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Restlessness (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Rhinorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Skin necrosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Ventricular extrasystoles (n/a - Unknown - Caused/Prolonged Hospitalisation);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009109296&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009084035;Spontaneous;2021-06-21 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Choking (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypertransaminasaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Lividity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Respiratory disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Urinary tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009084035&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009084327;Spontaneous;2021-06-21 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;18-64 Years;Not Specified;No;Male;Muscle injury (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Tenderness (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site rash (n/a - Recovered/Resolved - Other Medically Important Condition);COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19) [COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)] (S - Prophylaxis - Unknown - [n/a - n/a - n/a]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Unknown - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009084327&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009084939;Spontaneous;2021-06-21 00:00:00;Healthcare Professional;European Economic Area;Not available;Not Specified;Infant;No;Female;Bronchiolitis (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Eating disorder (n/a - Unknown - ),<BR><BR>Restlessness (n/a - Unknown - );VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Prophylaxis - Unknown - [n/a - n/a - Intramuscular - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009084939&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009085740;Spontaneous;2021-06-21 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Acne (n/a - Recovered/Resolved - ),<BR><BR>Decreased appetite (3d - Recovered/Resolved - ),<BR><BR>Erythema (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Fatigue (n/a - Recovered/Resolved - ),<BR><BR>Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009085740&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009087350;Spontaneous;2021-06-21 00:00:00;Non Healthcare Professional;European Economic Area;Not available;0-1 Month;Not Specified;No;Female;Agitation neonatal (n/a - Unknown - Other Medically Important Condition),<BR><BR>Anxiety (n/a - Unknown - Other Medically Important Condition),<BR><BR>Apathy (n/a - Unknown - Other Medically Important Condition),<BR><BR>Circadian rhythm sleep disorder (n/a - Unknown - Other Medically Important Condition),<BR><BR>Crying (n/a - Unknown - Other Medically Important Condition),<BR><BR>Decreased appetite (n/a - Unknown - Other Medically Important Condition),<BR><BR>Dyschezia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Infant irritability (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Sleep disorder (n/a - Unknown - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (C - n/a - n/a - [n/a - n/a - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - n/a - n/a - [n/a - n/a - Intramuscular]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009087350&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009051816;Spontaneous;2021-06-17 00:00:00;Non Healthcare Professional;European Economic Area;Not available;Not Specified;Infant;No;Female;Rash (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Respiratory distress (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Subglottic laryngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009051816&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009052506;Spontaneous;2021-06-17 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Vaccination site abscess (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009052506&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009054675;Spontaneous;2021-06-17 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;Yes;Female;Altered state of consciousness (1min - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Decreased activity (0d - Recovered/Resolved - ),<BR><BR>Hypotonia (0d - Recovered/Resolved - ),<BR><BR>Pallor (0d - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [10s - 1{DF} - Intramuscular - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009054675&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009009917;Spontaneous;2021-06-14 00:00:00;Healthcare Professional;European Economic Area;"Araújo ,M; Finelli, E; Prates, S. Re-vaccination after acute infantile hemorrhagic edema. Rev Port Imunoalergologia. 2019;27(Suppl 1):3-6";2 Months - 2 Years;Not Specified;No;Female;Acute haemorrhagic oedema of infancy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Irritability (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Localised oedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Oedema peripheral (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Rash macular (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular]),<BR><BR>[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009009917&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10009013567;Spontaneous;2021-06-14 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Benign enlargement of the subarachnoid spaces (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Cerebral haemorrhage (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Concussion (n/a - Unknown - ),<BR><BR>Contusion (n/a - Unknown - ),<BR><BR>Crying (n/a - Unknown - ),<BR><BR>Eye haemorrhage (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>High-pitched crying (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Neonatal disorder (n/a - Unknown - ),<BR><BR>Retinal haemorrhage (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Screaming (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Seizure (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Strabismus (n/a - Unknown - ),<BR><BR>Subdural haemorrhage (14d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Subdural hygroma (n/a - Unknown - Other Medically Important Condition),<BR><BR>Traumatic haemorrhage (14d - Recovered/Resolved - ),<BR><BR>Vitamin K deficiency (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Von Willebrand's factor activity decreased (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...;INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (C - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009013567&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008995710;Spontaneous;2021-06-12 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Febrile convulsion (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hyperpyrexia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]),<BR><BR>NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008995710&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008977026;Spontaneous;2021-06-11 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008977026&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008979997;Spontaneous;2021-06-11 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Coordination abnormal (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Resting tremor (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008979997&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008969327;Spontaneous;2021-06-10 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (0d - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular]);PREVENAR 13 SUSPENSION FOR INJECTION IN SINGLE DOSE VIAL [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197] (C - Prophylaxis - n/a - [n/a - .5mL - Intramuscular]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008969327&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008938929;Spontaneous;2021-06-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Seborrhoeic dermatitis (n/a - Recovering/Resolving - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [10s - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008938929&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008940116;Spontaneous;2021-06-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Decreased appetite (3d - Recovered/Resolved - ),<BR><BR>Extensive swelling of vaccinated limb (9d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pallor (9d - Recovered/Resolved - ),<BR><BR>Pyrexia (9d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Rash (9d - Recovered/Resolved - ),<BR><BR>Vaccination site erythema (9d - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular]);SYNFLORIX [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (C - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008940116&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008923831;Spontaneous;2021-06-07 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Administration site erythema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition),<BR><BR>Administration site inflammation (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition),<BR><BR>Pyrexia (4d - Recovered/Resolved - Life Threatening, Other Medically Important Condition),<BR><BR>Rash (3d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008923831&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008926249;Spontaneous;2021-06-07 00:00:00;Non Healthcare Professional;European Economic Area;Not available;0-1 Month;Not Specified;No;Female;Agitation neonatal (n/a - Unknown - Other Medically Important Condition),<BR><BR>Anxiety (n/a - Unknown - Other Medically Important Condition),<BR><BR>Apathy (n/a - Unknown - Other Medically Important Condition),<BR><BR>Circadian rhythm sleep disorder (n/a - Unknown - Other Medically Important Condition),<BR><BR>Crying (n/a - Unknown - Other Medically Important Condition),<BR><BR>Decreased appetite (n/a - Unknown - Other Medically Important Condition),<BR><BR>Dyschezia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Infant irritability (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Sleep disorder (n/a - Unknown - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (C - n/a - n/a - [n/a - n/a - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - n/a - n/a - [n/a - n/a - Intramuscular]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008926249&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008913524;Spontaneous;2021-06-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Apnoea (0d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Crying (0d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Loss of consciousness (0d - Recovered/Resolved - Other Medically Important Condition);VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008913524&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008895945;Spontaneous;2021-06-04 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Abnormal sleep-related event (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Agitation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Choking (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Constipation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Crying (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Decreased immune responsiveness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Dermatitis atopic (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Dysbiosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Enteritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Flatulence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Fungal skin infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Gastrointestinal mucormycosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Gastrooesophageal reflux disease (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>High-pitched crying (n/a - Unknown - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Hypertonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Mucous stools (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Muscle tightness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Oral candidiasis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Regurgitation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Sandifer's syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly),<BR><BR>Stool pH decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - n/a - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008895945&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008879962;Spontaneous;2021-06-03 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Apnoea (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008879962&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008881494;Spontaneous;2021-06-03 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Loss of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Loss of personal independence in daily activities (n/a - Unknown - );HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008881494&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008884879;Spontaneous;2021-06-03 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Dermatitis (n/a - Not Recovered/Not Resolved - Disabling);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008884879&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008868759;Spontaneous;2021-06-02 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Febrile convulsion (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (1d - Recovered/Resolved - );VAXELIS SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);NOT AVAILABLE (C - n/a - n/a - [n/a - 12.5mg - n/a]),<BR><BR>[PARACETAMOL] (C - n/a - n/a - [n/a - 240mg - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008868759&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008869889;Spontaneous;2021-06-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Extensive swelling of vaccinated limb (3d - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - ),<BR><BR>Skin mass (n/a - Unknown - ),<BR><BR>Vaccination site pain (3d - Recovering/Resolving - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008869889&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008874045;Spontaneous;2021-06-02 00:00:00;Non Healthcare Professional;European Economic Area;Not available;Not Specified;Infant;No;Male;Abnormal behaviour (n/a - Not Recovered/Not Resolved - Disabling);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008874045&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008874559;Spontaneous;2021-06-02 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Anaphylactic shock (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Cyanosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Heart rate increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Irritability (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Product complaint (n/a - Unknown - ),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008874559&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008852856;Spontaneous;2021-06-01 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Swelling of eyelid (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008852856&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008854667;Spontaneous;2021-06-01 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Anxiety (4h - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Crying (4h - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular]),<BR><BR>ROTATEQ [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)] (S - n/a - n/a - [n/a - 2mL - Oral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008854667&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008856808;Spontaneous;2021-06-01 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Vaccination site discomfort (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Vaccination site inflammation (n/a - Recovering/Resolving - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008856808&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008824784;Spontaneous;2021-05-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Diarrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Urinary tract infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular]),<BR><BR>ROTARIX ORAL SUSPENSION IN PRE-FILLED ORAL APPLICATOR [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Immunisation - Not applicable - [n/a - 1.5mL - Oral]),<BR><BR>SYNFLORIX SUSPENSION FOR INJECTION|PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (ADSORBED) [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008824784&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008833934;Spontaneous;2021-05-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Vaccination failure (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008833934&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008814431;Spontaneous;2021-05-28 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;Yes;Male;Choking (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Laryngospasm (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008814431&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008815748;Spontaneous;2021-05-28 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Granulomatous dermatitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Limb mass (n/a - Not Recovered/Not Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008815748&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008801275;Spontaneous;2021-05-27 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Eye movement disorder (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Febrile convulsion (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Respiratory arrest (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Skin discolouration (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008801275&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008786676;Spontaneous;2021-05-26 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Anxiety (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008786676&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008795419;Spontaneous;2021-05-26 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Apnoea (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypertonia (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008795419&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008777440;Spontaneous;2021-05-25 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Pneumonia haemophilus (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Vaccination failure (11d - Unknown - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008777440&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008742560;Spontaneous;2021-05-22 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Seizure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008742560&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008746135;Spontaneous;2021-05-22 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Psychomotor skills impaired (14d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008746135&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008727723;Spontaneous;2021-05-21 00:00:00;Healthcare Professional;Non European Economic Area;Not available;18-64 Years;Not Specified;No;Female;Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Dizziness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Nausea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Paraesthesia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Swollen tongue (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - n/a - n/a]),<BR><BR>TOZINAMERAN [TOZINAMERAN] (S - COVID-19 immunisation - Not applicable - [1d - n/a - n/a]);HYDROCORTISONE [HYDROCORTISONE, HYDROCORTISONE SODIUM SUCCINATE] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008727723&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008731779;Spontaneous;2021-05-21 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Enterococcal infection (n/a - Unknown - Other Medically Important Condition),<BR><BR>Injection site swelling (n/a - Not Recovered/Not Resolved - ),<BR><BR>Klebsiella infection (n/a - Unknown - Other Medically Important Condition),<BR><BR>Swelling (n/a - Not Recovered/Not Resolved - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;[CHOLECALCIFEROL CONCENTRATE (POWDER FORM), COLECALCIFEROL, COLECALCIFEROL CONCENTRATE (OILY FORM)] (C - n/a - Unknown - [n/a - 500[iU] - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008731779&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008741571;Spontaneous;2021-05-21 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008741571&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008708729;Spontaneous;2021-05-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Febrile convulsion (60d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008708729&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008718172;Spontaneous;2021-05-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Diarrhoea (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>General physical health deterioration (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Haematochezia (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Pallor (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008718172&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008702268;Spontaneous;2021-05-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Crying (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008702268&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008702334;Spontaneous;2021-05-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008702334&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008704488;Spontaneous;2021-05-19 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Eczema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Vomiting (2wk - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [40s - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008704488&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008680196;Spontaneous;2021-05-18 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyporesponsive to stimuli (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Drug withdrawn - [n/a - n/a - n/a]);PREVENAR SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008680196&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008685289;Spontaneous;2021-05-18 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Not Specified;Developmental regression (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Encephalopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Psychomotor skills impaired (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - Oral]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008685289&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008690799;Spontaneous;2021-05-18 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Not Specified;No;Male;Acute disseminated encephalomyelitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008690799&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008691610;Spontaneous;2021-05-18 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Insomnia (n/a - Recovered/Resolved - ),<BR><BR>Pyrexia (1d - Recovered/Resolved - ),<BR><BR>Speech disorder (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Tearfulness (n/a - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [10s - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008691610&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008668892;Spontaneous;2021-05-17 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Female;Application site erythema (2d - Recovering/Resolving - ),<BR><BR>Puncture site oedema (3d - Recovering/Resolving - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008668892&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008681689;Spontaneous;2021-05-17 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Cerebral haemorrhage (n/a - Recovered/Resolved - Life Threatening);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]),<BR><BR>ROTATEQ [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008681689&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008664490;Spontaneous;2021-05-15 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Dermatitis allergic (1h - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Unknown - [0d - .5mL - Intramuscular]);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (C - n/a - Unknown - [0d - n/a - n/a])...;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008664490&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008642785;Spontaneous;2021-05-14 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Crying (181d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Diarrhoea (181d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyperpyrexia (181d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vomiting (181d - Recovered/Resolved - Other Medically Important Condition);PREVENAR 13 SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]),<BR><BR>ROTARIX ORAL SUSPENSION IN PRE-FILLED ORAL APPLICATOR [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Immunisation - n/a - [n/a - 1.5mL - Oral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008642785&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008650525;Spontaneous;2021-05-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008650525&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008651177;Spontaneous;2021-05-14 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Psychomotor skills impaired (n/a - Recovering/Resolving - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (C - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008651177&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008652056;Spontaneous;2021-05-14 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Application site erythema (6d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Crying (2h - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Injection site oedema (6d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site induration (n/a - Unknown - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Unknown - [2min - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008652056&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008634182;Spontaneous;2021-05-13 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Breath holding (0d - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008634182&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008622048;Spontaneous;2021-05-12 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Crying (n/a - Unknown - ),<BR><BR>Lymphadenopathy (n/a - Unknown - ),<BR><BR>Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Speech disorder (n/a - Unknown - Other Medically Important Condition),<BR><BR>Stereotypy (n/a - Unknown - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008622048&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008624234;Spontaneous;2021-05-12 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Ecchymosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Unknown - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008624234&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008626099;Spontaneous;2021-05-12 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Not Specified;No;Male;Erythema (1d - Recovered/Resolved - ),<BR><BR>Oedema peripheral (1d - Recovered/Resolved - ),<BR><BR>Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Vaccination site oedema (1d - Recovered/Resolved - );HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008626099&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008601533;Spontaneous;2021-05-11 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Dyspnoea (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Gastroenteritis rotavirus (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Metabolic acidosis (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Nephrocalcinosis (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008601533&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008601588;Spontaneous;2021-05-11 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Erythema (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Joint swelling (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Oedema peripheral (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Serum sickness (3d - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008601588&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008610008;Spontaneous;2021-05-11 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pancytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008610008&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008611515;Spontaneous;2021-05-11 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Anxiety (n/a - Unknown - Life Threatening, Other Medically Important Condition),<BR><BR>Appetite disorder (n/a - Unknown - Life Threatening, Other Medically Important Condition),<BR><BR>Body temperature increased (n/a - Unknown - Life Threatening, Other Medically Important Condition),<BR><BR>Crying (n/a - Unknown - Life Threatening, Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - n/a]);SYNFLORIX [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (C - Immunisation - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008611515&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008599217;Spontaneous;2021-05-10 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Cough (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Decreased appetite (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Malaise (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Productive cough (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Wheezing (n/a - Recovering/Resolving - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008599217&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008602931;Spontaneous;2021-05-10 00:00:00;Non Healthcare Professional;European Economic Area;Not available;Not Specified;Not Specified;No;Female;Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Asthma (n/a - Unknown - ),<BR><BR>Developmental delay (n/a - Unknown - ),<BR><BR>Gastritis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (n/a - Unknown - ),<BR><BR>Pain (n/a - Unknown - ),<BR><BR>Pneumonia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Product complaint (n/a - Unknown - ),<BR><BR>Product quality issue (n/a - Unknown - ),<BR><BR>Sensory disturbance (n/a - Not Recovered/Not Resolved - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008602931&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008579899;Spontaneous;2021-05-08 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Vomiting (2h - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008579899&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008567358;Spontaneous;2021-05-07 00:00:00;Healthcare Professional;Non European Economic Area;Not available;Not Specified;Infant;No;Male;Labelled drug-drug interaction medication error (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Rash erythematous (n/a - Unknown - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (I - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])...;BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008567358&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008555335;Spontaneous;2021-05-06 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Erythema multiforme (n/a - Unknown - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008555335&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008561923;Spontaneous;2021-05-06 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Hypotonic-hyporesponsive episode (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pallor (1d - Recovered/Resolved - Other Medically Important Condition);VAXELIS SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Immunisation - Drug withdrawn - [1d - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008561923&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008533194;Spontaneous;2021-05-05 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Injection site vesicles (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Skin infection (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008533194&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008511838;Spontaneous;2021-05-03 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Cyanosis central (0d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypotonic-hyporesponsive episode (15min - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [0d - 1{DF} - Intramuscular]);[COLECALCIFEROL] (C - n/a - Dose not changed - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008511838&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008497836;Spontaneous;2021-04-30 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Autism spectrum disorder (n/a - Unknown - Other Medically Important Condition),<BR><BR>Communication disorder (n/a - Unknown - ),<BR><BR>Developmental delay (n/a - Unknown - ),<BR><BR>Intellectual disability (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008497836&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008498562;Spontaneous;2021-04-30 00:00:00;Healthcare Professional;European Economic Area;"Ivanova K et al. The analysis of autopsy protocols of the children who died within 1 year in Olomouc and Zlin region - possible connection between medical education of mothers and diagnosis of SIDS. Folia Societatis Medicinae Legalis Slovacae. 2016;6 (1):38-44 Ivanova K, Olecka I. Cumulative Effect Of Social Risk Factors Regarding Infants Who Died Of Suffocation. Czech-Slovak Pediatrics. 2020;75(8):458-464";2 Months - 2 Years;Not Specified;No;Female;Crying (n/a - Recovered/Resolved - ),<BR><BR>Sudden infant death syndrome (0d - Fatal - Results in Death, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008498562&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008479519;Spontaneous;2021-04-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apnoea (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypotonia (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Lividity (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008479519&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008484373;Spontaneous;2021-04-29 00:00:00;Healthcare Professional;European Economic Area;Not available;Not Specified;Child;No;Not Specified;Fall (n/a - Unknown - ),<BR><BR>Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Syncope (n/a - Unknown - Other Medically Important Condition),<BR><BR>Unevaluable event (n/a - Unknown - );HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008484373&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008464307;Spontaneous;2021-04-28 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Anxiety (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Crying (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Decreased appetite (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Irritability (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Nasal obstruction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Nasopharyngitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008464307&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008468916;Spontaneous;2021-04-28 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Hyperthermia (1d - Recovered/Resolved - ),<BR><BR>Hypotonic-hyporesponsive episode (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [1d - 1{DF} - Intramuscular]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - n/a - [1d - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008468916&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008472340;Spontaneous;2021-04-28 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Anxiety (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Crying (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypotonia (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Injection site oedema (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Irritability (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008472340&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008457285;Spontaneous;2021-04-27 00:00:00;Healthcare Professional;European Economic Area;"Slapal R. Specifics of cerebrovascular accidents in children.. Voice of pediatrics. 2021;21(3):22-4";2 Months - 2 Years;Not Specified;No;Male;Apathy (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Cerebral infarction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Collateral circulation (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Hypotonia (n/a - Unknown - ),<BR><BR>Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation);PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008457285&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008409749;Spontaneous;2021-04-23 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Application site erythema (7d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008409749&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008416533;Spontaneous;2021-04-23 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Urinary tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008416533&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008394300;Spontaneous;2021-04-22 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Autism spectrum disorder (n/a - Recovered/Resolved With Sequelae - Disabling),<BR><BR>Crying (n/a - Recovered/Resolved With Sequelae - Disabling),<BR><BR>Diarrhoea (n/a - Recovered/Resolved With Sequelae - Disabling),<BR><BR>Hypotonia (n/a - Recovered/Resolved With Sequelae - Disabling),<BR><BR>Psychomotor retardation (n/a - Recovered/Resolved With Sequelae - Disabling),<BR><BR>Pyrexia (n/a - Recovered/Resolved With Sequelae - Disabling),<BR><BR>Somnolence (n/a - Recovered/Resolved With Sequelae - Disabling),<BR><BR>Vomiting (n/a - Recovered/Resolved With Sequelae - Disabling);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008394300&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008396189;Spontaneous;2021-04-22 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Crying (n/a - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008396189&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008383155;Spontaneous;2021-04-21 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Body temperature increased (n/a - Recovering/Resolving - ),<BR><BR>Crying (n/a - Recovering/Resolving - ),<BR><BR>Fatigue (n/a - Recovering/Resolving - ),<BR><BR>Hypotonic-hyporesponsive episode (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Loss of consciousness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Somnolence (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008383155&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008364677;Spontaneous;2021-04-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Haematochezia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Tetanus immunisation - n/a - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008364677&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008366941;Spontaneous;2021-04-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Diarrhoea (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Diarrhoea haemorrhagic (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008366941&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008367494;Spontaneous;2021-04-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Clonus (0d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Cyanosis (0d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypertonia (0d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Salivary hypersecretion (0d - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008367494&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008374441;Spontaneous;2021-04-20 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Infant;No;Female;Sudden infant death syndrome (n/a - Fatal - Results in Death);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008374441&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008380252;Spontaneous;2021-04-20 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Constipation (3d - Recovered/Resolved - ),<BR><BR>Crying (6d - Recovered/Resolved - ),<BR><BR>Decreased appetite (n/a - Recovering/Resolving - ),<BR><BR>Gastrointestinal disorder (5d - Recovered/Resolved - ),<BR><BR>Gastrooesophageal reflux disease (5d - Recovered/Resolved - ),<BR><BR>Irritability (6d - Recovered/Resolved - ),<BR><BR>Malaise (5d - Recovered/Resolved - ),<BR><BR>Muscle spasms (5d - Recovered/Resolved - ),<BR><BR>Pallor (n/a - Recovering/Resolving - ),<BR><BR>Pyrexia (6d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Respiratory rate increased (4d - Recovered/Resolved - ),<BR><BR>Somnolence (n/a - Recovering/Resolving - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [1d - .5mL - Subcutaneous])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008380252&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008357380;Spontaneous;2021-04-19 00:00:00;Healthcare Professional;Non European Economic Area;Not available;Not Specified;Not Specified;No;Male;Apnoea (n/a - Unknown - Life Threatening, Disabling, Other Medically Important Condition),<BR><BR>Bradycardia (n/a - Unknown - Life Threatening, Disabling, Other Medically Important Condition),<BR><BR>Cardio-respiratory arrest neonatal (n/a - Unknown - Life Threatening, Disabling, Other Medically Important Condition),<BR><BR>Condition aggravated (n/a - Unknown - Life Threatening, Disabling),<BR><BR>Oxygen saturation decreased (n/a - Unknown - Life Threatening, Disabling);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>MENINGOCOCCAL POLYSACCHARIDE A + C VACCINE [MENINGOCOCCAL POLYSACCHARIDE A, MENINGOCOCCAL POLYSACCHARIDE C] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]);[PARACETAMOL] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008357380&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008361291;Spontaneous;2021-04-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Ataxia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (30h - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008361291&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008325927;Spontaneous;2021-04-16 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Incorrect route of product administration (n/a - Unknown - ),<BR><BR>Urticaria (2d - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008325927&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008327668;Spontaneous;2021-04-16 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Haematochezia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Intussusception (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [n/a - n/a - Oral]),<BR><BR>[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008327668&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008328323;Spontaneous;2021-04-16 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Crying (3h - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008328323&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008331784;Spontaneous;2021-04-16 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Dermatitis atopic (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Somnolence (n/a - Recovered/Resolved - ),<BR><BR>Tearfulness (n/a - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008331784&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008314534;Spontaneous;2021-04-15 00:00:00;Non Healthcare Professional;European Economic Area;Not available;Not Specified;Not Specified;No;Male;Developmental delay (n/a - Recovered/Resolved - ),<BR><BR>Paralysis (14d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Posture abnormal (n/a - Recovered/Resolved - );[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008314534&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008316690;Spontaneous;2021-04-15 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Livedo reticularis (0d - Recovered/Resolved - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008316690&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008323824;Spontaneous;2021-04-15 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Eye movement disorder (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Loss of consciousness (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);PREVENAR 13 SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE] (S - Prophylaxis - Drug withdrawn - [1d - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008323824&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008304981;Spontaneous;2021-04-14 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Atopy (n/a - Unknown - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [n/a - 1.5mL - Buccal]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008304981&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008307603;Spontaneous;2021-04-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Bordetella test negative (n/a - Unknown - ),<BR><BR>Cyanosis (n/a - Not Recovered/Not Resolved - ),<BR><BR>Pertussis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008307603&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008308706;Spontaneous;2021-04-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Dermatitis exfoliative generalised (19d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Rash pruritic (19d - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;[COLECALCIFEROL] (C - n/a - n/a - [n/a - 2[drp] - Oral]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008308706&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008285054;Spontaneous;2021-04-13 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Asthenia (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Cold sweat (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Delusional perception (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Dizziness (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Fear (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hallucination (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Injection site pain (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Nightmare (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Screaming (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008285054&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008292698;Spontaneous;2021-04-13 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Anxiety (3h - Unknown - Other Medically Important Condition),<BR><BR>Apathy (n/a - Unknown - Other Medically Important Condition),<BR><BR>Crying (3h - Unknown - Other Medically Important Condition),<BR><BR>Decreased activity (n/a - Unknown - Other Medically Important Condition),<BR><BR>Eating disorder (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Vaccination site reaction (n/a - Unknown - Other Medically Important Condition),<BR><BR>Vomiting (n/a - Unknown - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008292698&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008278996;Spontaneous;2021-04-12 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Abnormal behaviour (n/a - Recovered/Resolved - Life Threatening),<BR><BR>Altered state of consciousness (n/a - Recovered/Resolved - Life Threatening),<BR><BR>Inflammation (n/a - Recovered/Resolved - Life Threatening),<BR><BR>Pneumonia (n/a - Recovered/Resolved - Life Threatening);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - .5mL - n/a]),<BR><BR>[BACILLUS CALMETTE-GUERIN VACCINE] (S - n/a - n/a - [n/a - .1mL - Subcutaneous]),<BR><BR>[HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGEN (RDNA), ALUMINIUM HYDROXIDE, HEPATITIS B SURFACE ANTIGEN, ALGELDRATE] (S - n/a - n/a - [n/a - 1mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008278996&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008282222;Spontaneous;2021-04-12 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Respiratory failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...;[CALCIUM CHLORIDE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[LACTULOSE] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[POTASSIUM CITRATE] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[VITAMIN D] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[VITAMINS NOS] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008282222&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008282785;Spontaneous;2021-04-12 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Faeces discoloured (n/a - Unknown - Other Medically Important Condition),<BR><BR>Irritability (n/a - Unknown - Other Medically Important Condition),<BR><BR>Mucous stools (n/a - Unknown - Other Medically Important Condition),<BR><BR>Nervous system disorder (n/a - Unknown - Other Medically Important Condition),<BR><BR>Nervousness (n/a - Unknown - Other Medically Important Condition),<BR><BR>Periorbital swelling (n/a - Unknown - Other Medically Important Condition),<BR><BR>Rhinorrhoea (n/a - Unknown - Other Medically Important Condition),<BR><BR>Screaming (n/a - Unknown - Other Medically Important Condition),<BR><BR>Tearfulness (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008282785&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008283680;Spontaneous;2021-04-12 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Seizure (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - 1.5mL - Oral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008283680&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008251203;Spontaneous;2021-04-09 00:00:00;Healthcare Professional;European Economic Area;Not available;12-17 Years;Not Specified;No;Male;Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition),<BR><BR>Product administered to patient of inappropriate age (n/a - Unknown - );HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008251203&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008253519;Spontaneous;2021-04-09 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - n/a]);SYNFLORIX [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008253519&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008236643;Spontaneous;2021-04-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Insomnia (1mo - Recovered/Resolved - ),<BR><BR>Poor quality sleep (1mo - Recovered/Resolved - ),<BR><BR>Psychomotor skills impaired (1mo - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site oedema (14d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008236643&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008237270;Spontaneous;2021-04-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Eczema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008237270&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008237526;Spontaneous;2021-04-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Application site erythema (n/a - Recovered/Resolved - ),<BR><BR>Vaccination site oedema (1mo - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site warmth (n/a - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008237526&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008238489;Spontaneous;2021-04-08 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Petechiae (n/a - Unknown - ),<BR><BR>Thrombocytopenia (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [n/a - n/a - Oral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008238489&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008239274;Spontaneous;2021-04-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Crying (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Faeces discoloured (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Gaze palsy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Infantile spitting up (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Seizure (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Somnolence (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Tremor (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Unresponsive to stimuli (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008239274&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008245508;Spontaneous;2021-04-08 00:00:00;Healthcare Professional;European Economic Area;Not available;Not Specified;Infant;No;Female;Cold sweat (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Unresponsive to stimuli (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008245508&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008211920;Spontaneous;2021-04-07 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Salivary hypersecretion (n/a - Unknown - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008211920&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008214186;Spontaneous;2021-04-07 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Facial paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008214186&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008216885;Spontaneous;2021-04-07 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Crying (30min - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pallor (1min - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Tachycardia (0d - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular]),<BR><BR>ROTATEQ [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)] (S - Rotavirus immunisation - Not applicable - [n/a - 2mL - Oral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008216885&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008219254;Spontaneous;2021-04-07 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Extensive swelling of vaccinated limb (5d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site erythema (5d - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008219254&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008222709;Spontaneous;2021-04-07 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Crying (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008222709&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008223662;Spontaneous;2021-04-07 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008223662&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008224901;Spontaneous;2021-04-07 00:00:00;Healthcare Professional;European Economic Area;Not available;Not Specified;Infant;No;Male;Injection site abscess (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Injection site erythema (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Injection site swelling (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);VAXELIS SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (C - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008224901&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008226332;Spontaneous;2021-04-07 00:00:00;Healthcare Professional;European Economic Area;Not available;Not Specified;Infant;No;Female;Meningitis haemophilus (n/a - Unknown - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008226332&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008229847;Spontaneous;2021-04-07 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Seizure (n/a - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008229847&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008230268;Spontaneous;2021-04-07 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Neonate (Preterm and Term newborns);No;Female;Hypotonia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vaccination complication (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008230268&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008232624;Spontaneous;2021-04-07 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Apnoea (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Bradycardia (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);VAXELIS SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Prophylaxis - Drug withdrawn - [1d - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008232624&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008213079;Spontaneous;2021-04-06 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Dysphonia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Haemangioma (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Livedo reticularis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Petechiae (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Rash (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Restlessness (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Rhinorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Spontaneous haematoma (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Vaccination site induration (n/a - Unknown - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...;[COLECALCIFEROL] (C - Immunisation - n/a - [n/a - 3[drp] - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008213079&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008199290;Spontaneous;2021-04-05 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Dermatitis allergic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Livedo reticularis (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>[ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT] (S - Immunisation - Not applicable - [n/a - n/a - Oral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008199290&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008171110;Spontaneous;2021-04-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Enteritis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Febrile convulsion (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Hemiparesis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Pleocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Status epilepticus (n/a - Unknown - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008171110&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008154955;Spontaneous;2021-04-01 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular]);PREVENAR 13 SUSPENSION FOR INJECTION IN SINGLE DOSE VIAL [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197] (C - Prophylaxis - n/a - [n/a - .5mL - Intramuscular]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008154955&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008166402;Spontaneous;2021-04-01 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Agranulocytosis (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Neutropenia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - ),<BR><BR>Restlessness (n/a - Unknown - );VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Prophylaxis - Unknown - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008166402&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008166609;Spontaneous;2021-04-01 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apnoea (2d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Crying (n/a - Recovered/Resolved - ),<BR><BR>Cyanosis (2d - Recovered/Resolved - ),<BR><BR>Disorientation (n/a - Unknown - ),<BR><BR>Gastrooesophageal reflux disease (n/a - Unknown - ),<BR><BR>Hypotonic-hyporesponsive episode (1d - Recovered/Resolved - ),<BR><BR>Hypoxia (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Lethargy (n/a - Unknown - ),<BR><BR>Leukocytosis (n/a - Unknown - ),<BR><BR>Loss of consciousness (n/a - Unknown - Other Medically Important Condition),<BR><BR>Oral mucosal discolouration (2d - Recovered/Resolved - ),<BR><BR>Pallor (2d - Recovered/Resolved - ),<BR><BR>Pyrexia (n/a - Recovered/Resolved - ),<BR><BR>Somnolence (n/a - Recovered/Resolved - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...;[MYCOBACTERIUM BOVIS, DANISH STRAIN 1331] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008166609&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008152298;Spontaneous;2021-03-31 00:00:00;Healthcare Professional;European Economic Area;Not available;Not Specified;Child;No;Not Specified;Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008152298&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008153424;Spontaneous;2021-03-31 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Arthritis (6d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Balance disorder (1d - Recovered/Resolved - ),<BR><BR>Crying (n/a - Recovered/Resolved - ),<BR><BR>Gait disturbance (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Myalgia (6d - Recovered/Resolved - ),<BR><BR>Restlessness (0d - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);[COLECALCIFEROL] (C - n/a - n/a - );"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008153424&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008136243;Spontaneous;2021-03-30 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Female;Application site erythema (5d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008136243&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008140139;Spontaneous;2021-03-30 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Abdominal pain upper (n/a - Unknown - Other Medically Important Condition),<BR><BR>Constipation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Food allergy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Mucous stools (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Parenteral]);[LACTULOSE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>[NYSTATIN] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>[OMEPRAZOLE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008140139&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008125711;Spontaneous;2021-03-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Emotional distress (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Rash erythematous (20min - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Rash papular (20min - Recovered/Resolved - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [n/a - 1.5mL - Oral]);[OMEPRAZOLE] (C - Gastrooesophageal reflux disease - n/a - [n/a - 2.5mL - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008125711&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008080538;Spontaneous;2021-03-26 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Cyanosis (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Febrile convulsion (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypertonia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Staring (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);PREVENAR 13 SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular]),<BR><BR>ROTARIX ORAL SUSPENSION ROTAVIRUS VACCINE, LIVE [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Immunisation - n/a - [n/a - 1{DF} - Oral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008080538&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008083700;Spontaneous;2021-03-26 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Abdominal pain (n/a - Unknown - Other Medically Important Condition),<BR><BR>Anxiety (n/a - Unknown - Other Medically Important Condition),<BR><BR>Crying (n/a - Unknown - Other Medically Important Condition),<BR><BR>Decreased interest (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Dermatitis atopic (1mo - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Dermatitis atopic (2wk - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Dysphonia (2wk - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Flatulence (n/a - Unknown - Other Medically Important Condition),<BR><BR>Infantile spitting up (1wk - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Infantile spitting up (n/a - Unknown - Other Medically Important Condition),<BR><BR>Oral candidiasis (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Rhinitis (2wk - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Sleep disorder (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Somnolence (n/a - Unknown - Other Medically Important Condition),<BR><BR>Speech disorder developmental (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site pain (n/a - Unknown - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008083700&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008085160;Spontaneous;2021-03-26 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Not Specified;No;Male;Bradycardia (5min - Recovered/Resolved - Life Threatening),<BR><BR>Oxygen saturation decreased (5min - Recovered/Resolved - Life Threatening),<BR><BR>Respiratory arrest (5min - Recovered/Resolved - Life Threatening);VAXELIS SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008085160&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008085391;Spontaneous;2021-03-26 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Pyrexia (n/a - Unknown - ),<BR><BR>Seizure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008085391&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008089123;Spontaneous;2021-03-26 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Rash macular (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Swelling (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008089123&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008068100;Spontaneous;2021-03-25 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Cyanosis (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Malaise (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008068100&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008070133;Spontaneous;2021-03-25 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Female;Erysipelas (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vaccination site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vaccination site swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008070133&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008071639;Spontaneous;2021-03-25 00:00:00;Non Healthcare Professional;European Economic Area;Not available;12-17 Years;Not Specified;No;Female;Apathy (n/a - Unknown - Other Medically Important Condition),<BR><BR>Crying (n/a - Unknown - Other Medically Important Condition),<BR><BR>Diarrhoea (n/a - Unknown - Other Medically Important Condition),<BR><BR>Poor feeding infant (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Somnolence (n/a - Unknown - Other Medically Important Condition),<BR><BR>Weight gain poor (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008071639&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008077249;Spontaneous;2021-03-25 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Adverse drug reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Ill-defined disorder - Unknown - [56d - n/a - Parenteral]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Ill-defined disorder - Unknown - [315d - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008077249&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008077638;Spontaneous;2021-03-25 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;0-1 Month;Not Specified;No;Female;Rash papular (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008077638&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008057001;Spontaneous;2021-03-24 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;0-1 Month;Not Specified;No;Male;Constipation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral])...;[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - Constipation - Unknown - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008057001&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008058384;Spontaneous;2021-03-24 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Insomnia (n/a - Not Recovered/Not Resolved - ),<BR><BR>Psychomotor skills impaired (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Tearfulness (n/a - Not Recovered/Not Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [3s - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008058384&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008058624;Spontaneous;2021-03-24 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Abnormal behaviour (n/a - Unknown - ),<BR><BR>Aggression (n/a - Unknown - ),<BR><BR>Deafness (n/a - Unknown - Other Medically Important Condition),<BR><BR>Disturbance in attention (n/a - Unknown - ),<BR><BR>Learning disorder (n/a - Unknown - ),<BR><BR>Neurosensory hypoacusis (n/a - Unknown - ),<BR><BR>Psychomotor hyperactivity (n/a - Unknown - ),<BR><BR>Psychomotor skills impaired (n/a - Unknown - ),<BR><BR>Social avoidant behaviour (n/a - Unknown - ),<BR><BR>Speech disorder developmental (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])...;[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Rhinitis - Not applicable - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008058624&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008062885;Spontaneous;2021-03-24 00:00:00;Healthcare Professional;European Economic Area;"Van Den Akker, M; Smolders, D; Mahieu, S; Bonouvrie, K; Van der Werf Ten Bosch,J.. Primary IgA-mediated Autoimmune Hemolytic Anemia in an Infant Successfully Treated with Rituximab. J Pediatr Hematol Oncol. 2020;42:615-619";2 Months - 2 Years;Not Specified;No;Female;Autoimmune haemolytic anaemia (3mo - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Chills (n/a - Unknown - Other Medically Important Condition),<BR><BR>Decreased appetite (n/a - Unknown - Other Medically Important Condition),<BR><BR>Haemolysis (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypertension (n/a - Unknown - Other Medically Important Condition),<BR><BR>Illness (n/a - Unknown - Other Medically Important Condition),<BR><BR>Livedo reticularis (n/a - Unknown - Other Medically Important Condition),<BR><BR>Ocular icterus (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pallor (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Tachycardia (n/a - Unknown - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008062885&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008039633;Spontaneous;2021-03-23 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Rash (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site erythema (n/a - Recovered/Resolved - ),<BR><BR>Vaccination site induration (n/a - Recovered/Resolved - ),<BR><BR>Vaccination site oedema (n/a - Recovered/Resolved - ),<BR><BR>Vaccination site oedema (n/a - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [1d - .5mL - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008039633&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008049669;Spontaneous;2021-03-23 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Cyanosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Floppy infant (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - Not applicable - [n/a - n/a - n/a]);[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008049669&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008024944;Spontaneous;2021-03-22 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Dermatitis atopic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Hypersensitivity (n/a - Not Recovered/Not Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [3s - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008024944&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007986877;Spontaneous;2021-03-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Clonus (0d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007986877&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007987435;Spontaneous;2021-03-19 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Pyrexia (n/a - Recovered/Resolved With Sequelae - Life Threatening),<BR><BR>Sleep disorder (n/a - Recovered/Resolved With Sequelae - Life Threatening);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007987435&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007988585;Spontaneous;2021-03-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007988585&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007993312;Spontaneous;2021-03-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Body temperature increased (2h - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Eye movement disorder (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypertonia (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Irritability (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Mood altered (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Restlessness (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Unresponsive to stimuli (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (1h - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;[PARACETAMOL] (C - n/a - n/a - [n/a - 60mg - Rectal]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007993312&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007993372;Spontaneous;2021-03-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Not Specified;Body temperature increased (1d - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007993372&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007997667;Spontaneous;2021-03-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Eczema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Immunisation - Unknown - [n/a - n/a - n/a]),<BR><BR>[N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, ALGELDRATE] (S - Prophylaxis - Unknown - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007997667&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007998506;Spontaneous;2021-03-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Psychomotor skills impaired (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Speech disorder developmental (n/a - Recovering/Resolving - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [9mo - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007998506&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008000887;Spontaneous;2021-03-19 00:00:00;Healthcare Professional;Non European Economic Area;Not available;Not Specified;Child;No;Not Specified;Pertussis (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008000887&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008001990;Spontaneous;2021-03-19 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Floppy infant (0d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pallor (0d - Recovered/Resolved - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Parenteral]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008001990&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10008002381;Spontaneous;2021-03-19 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Eye movement disorder (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypotonic-hyporesponsive episode (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Muscle rigidity (1d - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular]);[PARACETAMOL] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008002381&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007974138;Spontaneous;2021-03-18 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Acute respiratory failure (1mo - Recovered/Resolved - Life Threatening);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;[ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE, SODIUM CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE, SODIUM CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE GEL, DRIED USP, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALUMINIUM HYDROXIDE GEL, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, SODIUM ALGINATE] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[SODIUM FEREDETATE] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007974138&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007976198;Spontaneous;2021-03-18 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apathy (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007976198&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007976249;Spontaneous;2021-03-18 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007976249&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007976332;Spontaneous;2021-03-18 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Hypotonic-hyporesponsive episode (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007976332&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007984886;Spontaneous;2021-03-18 00:00:00;Healthcare Professional;Non European Economic Area;Not available;Not Specified;Not Specified;No;Male;Apnoea (n/a - Unknown - Life Threatening, Disabling),<BR><BR>Bradycardia (n/a - Unknown - Life Threatening, Disabling),<BR><BR>Cardio-respiratory arrest neonatal (n/a - Unknown - Life Threatening, Disabling),<BR><BR>Condition aggravated (n/a - Unknown - Life Threatening, Disabling),<BR><BR>Oxygen saturation decreased (n/a - Unknown - Life Threatening, Disabling);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>[N. MENINGITIDIS GROUP C POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE] (S - n/a - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]);[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007984886&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007954141;Spontaneous;2021-03-17 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Diarrhoea (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007954141&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007971273;Spontaneous;2021-03-17 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Flatulence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Infant dyschezia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Infantile back arching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown]);[PARACETAMOL, PARACETAMOL PH. EUR.] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007971273&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007971281;Spontaneous;2021-03-17 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Agitation (n/a - Unknown - ),<BR><BR>Bronchitis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Dermatitis (n/a - Unknown - ),<BR><BR>Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Gastrointestinal disorder (n/a - Unknown - ),<BR><BR>Gastrointestinal motility disorder (n/a - Unknown - ),<BR><BR>General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Hyperresponsive to stimuli (n/a - Unknown - ),<BR><BR>Lymphadenopathy (n/a - Unknown - ),<BR><BR>Nerve block (n/a - Unknown - ),<BR><BR>Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Rash (n/a - Unknown - ),<BR><BR>Tachypnoea (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Upper respiratory tract infection (n/a - Unknown - ),<BR><BR>Viral infection (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007971281&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007943385;Spontaneous;2021-03-16 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Breath holding (31d - Recovering/Resolving - ),<BR><BR>Crying (31d - Recovering/Resolving - ),<BR><BR>Irritability postvaccinal (31d - Recovering/Resolving - ),<BR><BR>Muscle spasms (31d - Recovering/Resolving - ),<BR><BR>Productive cough (31d - Recovering/Resolving - ),<BR><BR>Pyrexia (31d - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Restlessness (31d - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Rhinitis (31d - Recovering/Resolving - ),<BR><BR>Tremor (31d - Recovering/Resolving - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007943385&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007950227;Spontaneous;2021-03-16 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Body temperature increased (14d - Recovering/Resolving - ),<BR><BR>Eczema (15wk - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Puncture site erythema (15wk - Recovering/Resolving - ),<BR><BR>Rash (15wk - Recovering/Resolving - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007950227&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007900228;Spontaneous;2021-03-12 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Eczema infantile (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Scratch (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Skin haemorrhage (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - n/a - Parenteral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007900228&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007905754;Spontaneous;2021-03-12 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;0-1 Month;Not Specified;No;Female;Constipation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Incorrect route of product administration (n/a - Unknown - );BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]);[OMEPRAZOLE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007905754&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007876870;Spontaneous;2021-03-10 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Not Specified;Yes;Male;Apnoea (45min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Eye discharge (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Fatigue (n/a - Unknown - ),<BR><BR>Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>General physical health deterioration (n/a - Unknown - ),<BR><BR>Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Screaming (n/a - Unknown - ),<BR><BR>Slow response to stimuli (45min - Recovered/Resolved - Caused/Prolonged Hospitalisation);ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [n/a - n/a - Oral])...;[COLECALCIFEROL, SODIUM FLUORIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007876870&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007877306;Spontaneous;2021-03-10 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Dermatitis atopic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Toxic skin eruption (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007877306&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007879778;Spontaneous;2021-03-10 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007879778&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007879828;Spontaneous;2021-03-10 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [5s - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007879828&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007879924;Spontaneous;2021-03-10 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Crying (3h - Recovered/Resolved - ),<BR><BR>Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [5s - 1{DF} - n/a - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007879924&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007881592;Spontaneous;2021-03-10 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007881592&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007860337;Spontaneous;2021-03-09 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Myoclonic epilepsy (7min - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Seizure (7min - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Tremor (7min - Recovering/Resolving - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007860337&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007863088;Spontaneous;2021-03-09 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Decreased appetite (9d - Recovered/Resolved - ),<BR><BR>Dermatitis atopic (2mo - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Diarrhoea (9d - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [2s - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007863088&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007864277;Spontaneous;2021-03-09 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypotonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007864277&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007864779;Spontaneous;2021-03-09 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Bradykinesia (n/a - Unknown - ),<BR><BR>Inappropriate schedule of product administration (n/a - Unknown - ),<BR><BR>Muscle disorder (n/a - Recovered/Resolved - ),<BR><BR>Myosclerosis (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Peripheral swelling (n/a - Recovered/Resolved - ),<BR><BR>Product administered to patient of inappropriate age (n/a - Unknown - ),<BR><BR>Speech disorder developmental (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007864779&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007865242;Spontaneous;2021-03-09 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Respiratory arrest (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Unknown - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007865242&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007865658;Spontaneous;2021-03-09 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Female;Decreased appetite (n/a - Recovered/Resolved - ),<BR><BR>Inappropriate affect (n/a - Unknown - ),<BR><BR>Insomnia (n/a - Unknown - ),<BR><BR>Opisthotonus (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Vaccination site oedema (n/a - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Diphtheria immunisation, Haemophilus influenzae type b immunisation, Hepatitis B immunisation, Pertussis immunisation, Polio immunisation, Tetanus immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007865658&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007865823;Spontaneous;2021-03-09 00:00:00;Non Healthcare Professional;European Economic Area;Not available;Not Specified;Infant;No;Male;Injection site erythema (n/a - Recovered/Resolved - ),<BR><BR>Injection site pain (n/a - Recovered/Resolved - ),<BR><BR>Injection site swelling (n/a - Recovered/Resolved - ),<BR><BR>Myosclerosis (3wk - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007865823&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007868600;Spontaneous;2021-03-09 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Apathy (4d - Recovered/Resolved With Sequelae - Other Medically Important Condition),<BR><BR>Pyrexia (0d - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007868600&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007869147;Spontaneous;2021-03-09 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Constipation (4d - Recovered/Resolved - ),<BR><BR>Decreased appetite (3d - Recovered/Resolved - ),<BR><BR>Vaccination site erythema (6d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site induration (6d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site oedema (6d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site pain (6d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007869147&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007848730;Spontaneous;2021-03-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Cough (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition),<BR><BR>Rhinitis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007848730&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007850308;Spontaneous;2021-03-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Krabbe's disease (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Therapeutic product ineffective (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007850308&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007850720;Spontaneous;2021-03-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Febrile convulsion (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007850720&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007853089;Spontaneous;2021-03-08 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Consciousness fluctuating (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Encephalitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Motor dysfunction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (4d - Recovered/Resolved - ),<BR><BR>Rash erythematous (n/a - Recovered/Resolved - ),<BR><BR>Restlessness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Status epilepticus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007853089&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007855228;Spontaneous;2021-03-08 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Psychomotor skills impaired (n/a - Recovering/Resolving - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007855228&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007810955;Spontaneous;2021-03-06 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Cold sweat (n/a - Recovering/Resolving - Life Threatening),<BR><BR>Hypotonia (n/a - Recovering/Resolving - Life Threatening),<BR><BR>Irritability (n/a - Recovering/Resolving - Life Threatening),<BR><BR>Pallor (n/a - Recovering/Resolving - Life Threatening),<BR><BR>Vomiting (n/a - Recovering/Resolving - Life Threatening);VAXELIS SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007810955&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007811001;Spontaneous;2021-03-06 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Abdominal pain (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Eyelid oedema (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Fatigue (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Irritability (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Oedema peripheral (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007811001&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007812369;Spontaneous;2021-03-06 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Abnormal behaviour (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Fontanelle bulging (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>High-pitched crying (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Meningism (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007812369&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007796593;Spontaneous;2021-03-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Abdominal pain (25d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Diarrhoea (25d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Restlessness (25d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vomiting (25d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007796593&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007803428;Spontaneous;2021-03-05 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Decreased appetite (n/a - Recovered/Resolved - Life Threatening),<BR><BR>Dry skin (n/a - Not Recovered/Not Resolved - Life Threatening),<BR><BR>Fatigue (n/a - Recovered/Resolved - Life Threatening),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Life Threatening),<BR><BR>Rash (n/a - Not Recovered/Not Resolved - Life Threatening),<BR><BR>Restlessness (n/a - Recovered/Resolved - Life Threatening),<BR><BR>Somnolence (n/a - Recovered/Resolved - Life Threatening),<BR><BR>Vaccination site swelling (n/a - Recovered/Resolved - Life Threatening);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007803428&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007803735;Spontaneous;2021-03-05 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Decreased appetite (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling),<BR><BR>Dry skin (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling),<BR><BR>Epistaxis (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling),<BR><BR>Fatigue (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling),<BR><BR>Pyrexia (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling),<BR><BR>Rash (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007803735&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007808572;Spontaneous;2021-03-05 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Administration site induration (5d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Application site erythema (5d - Recovered/Resolved - ),<BR><BR>Application site erythema (5d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Puncture site oedema (5d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007808572&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007808673;Spontaneous;2021-03-05 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Administration site induration (3d - Recovered/Resolved - ),<BR><BR>Application site erythema (3d - Recovered/Resolved - ),<BR><BR>Eczema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Puncture site oedema (3d - Recovered/Resolved - ),<BR><BR>Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007808673&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007785359;Spontaneous;2021-03-04 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Strabismus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>VIth nerve paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007785359&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007786551;Spontaneous;2021-03-04 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;General physical health deterioration (3a - Recovered/Resolved With Sequelae - Other Medically Important Condition),<BR><BR>Laryngitis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition),<BR><BR>Tonsillar hypertrophy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007786551&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007786775;Spontaneous;2021-03-04 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Abdominal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Balance disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Vaccination site reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);[DESLORATADINE] (C - Hypersensitivity - n/a - [n/a - 2.5mL - Oral]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007786775&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007786805;Spontaneous;2021-03-04 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Abdominal pain upper (2d - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Diarrhoea (2d - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Poor feeding infant (2d - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - n/a - Parenteral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007786805&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007787344;Spontaneous;2021-03-04 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Hypotonic-hyporesponsive episode (2h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular]),<BR><BR>ROTARIX ORAL ROTAVIRUS VACCINE (LIVE, ATTENUATED) [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED)] (S - Prophylaxis - n/a - [n/a - n/a - Oral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007787344&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007787463;Spontaneous;2021-03-04 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Apparent life threatening event (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Cyanosis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]),<BR><BR>ROTARIX ORAL ROTAVIRUS VACCINE (LIVE, ATTENUATED) [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED)] (S - Immunisation - n/a - [n/a - n/a - Oral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007787463&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007790576;Spontaneous;2021-03-04 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Cyanosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Screaming (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - n/a - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007790576&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007792402;Spontaneous;2021-03-04 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Vaccination site erythema (5d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site oedema (5d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007792402&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007794422;Spontaneous;2021-03-04 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Seizure (n/a - Unknown - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007794422&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007773377;Spontaneous;2021-03-03 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Dyskinesia (n/a - Recovered/Resolved With Sequelae - Disabling),<BR><BR>Echolalia (n/a - Recovered/Resolved With Sequelae - Disabling),<BR><BR>Movement disorder (n/a - Recovered/Resolved With Sequelae - Disabling),<BR><BR>Sleep disorder (n/a - Recovered/Resolved With Sequelae - Disabling);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007773377&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007778216;Spontaneous;2021-03-03 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Seizure (20min - Recovered/Resolved - Caused/Prolonged Hospitalisation);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007778216&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007760521;Spontaneous;2021-03-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Blister (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]),<BR><BR>ROTATEQ [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007760521&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007760616;Spontaneous;2021-03-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Crying (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Urticaria (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007760616&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007760718;Spontaneous;2021-03-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperhidrosis (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Muscle rigidity (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Neonatal hypoxia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Dose not changed - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007760718&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007761051;Spontaneous;2021-03-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyporesponsive to stimuli (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Hypotonia (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Ventricular tachycardia (n/a - Recovering/Resolving - Other Medically Important Condition);INFANRIX HEXA POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007761051&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007761176;Spontaneous;2021-03-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apparent life threatening event (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Decreased activity (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pallor (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007761176&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007763556;Spontaneous;2021-03-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007763556&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007765415;Spontaneous;2021-03-02 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Male;Diarrhoea (n/a - Unknown - ),<BR><BR>Hyperhidrosis (1d - Recovered/Resolved - ),<BR><BR>Lymphadenopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Rash (n/a - Unknown - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007765415&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007765640;Spontaneous;2021-03-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [2s - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007765640&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007767976;Spontaneous;2021-03-02 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Not Specified;No;Female;Choking (n/a - Unknown - Other Medically Important Condition),<BR><BR>Contusion (n/a - Unknown - ),<BR><BR>Groin pain (n/a - Unknown - ),<BR><BR>Inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Inguinal hernia (n/a - Unknown - ),<BR><BR>Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Swelling (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL CONJUGATE VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007767976&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007771109;Spontaneous;2021-03-02 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Male;Cellulitis (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Medication error (n/a - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007771109&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007747946;Spontaneous;2021-03-01 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007747946&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007752050;Spontaneous;2021-03-01 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007752050&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007743725;Spontaneous;2021-02-28 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Apnoea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Apparent life threatening event (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Infantile back arching (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]),<BR><BR>ROTARIX ORAL ROTAVIRUS VACCINE (LIVE, ATTENUATED) [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED)] (S - Immunisation - n/a - [n/a - n/a - Oral])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007743725&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007740444;Spontaneous;2021-02-27 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Local reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007740444&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007733346;Spontaneous;2021-02-26 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Seizure (2min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007733346&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007733977;Spontaneous;2021-02-26 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Febrile convulsion (3min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Vaccination site pain (n/a - Unknown - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [5s - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007733977&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007734868;Spontaneous;2021-02-26 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Mood swings (5d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Psychomotor hyperactivity (7d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Screaming (10d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007734868&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007735304;Spontaneous;2021-02-26 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Behaviour disorder (40min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (40min - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007735304&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007717873;Spontaneous;2021-02-25 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007717873&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007720726;Spontaneous;2021-02-25 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007720726&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007722468;Spontaneous;2021-02-25 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007722468&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007722496;Spontaneous;2021-02-25 00:00:00;Healthcare Professional;Non European Economic Area;Not available;65-85 Years;Not Specified;No;Male;Type I hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...;ESOMEPRAZOLE [ESOMEPRAZOLE] (C - n/a - Dose not changed - [n/a - 40mg - Oral]),<BR><BR>[CALCIUM FOLINATE] (C - n/a - Dose not changed - [n/a - 15mg - Oral]),<BR><BR>[PHENOXYMETHYLPENICILLIN] (C - n/a - Dose not changed - [n/a - n/a - Oral]),<BR><BR>[SULFAMETHOXAZOLE, TRIMETHOPRIM] (C - n/a - Dose not changed - [n/a - n/a - n/a]),<BR><BR>[URSODEOXYCHOLIC ACID] (C - n/a - Dose not changed - [3d - 250mg - Oral]),<BR><BR>[VALACICLOVIR] (C - n/a - Dose not changed - [n/a - 500mg - Oral]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007722496&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007707154;Spontaneous;2021-02-24 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Henoch-Schonlein purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Rash papular (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);VAXELIS [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular]);ROTATEQ [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)] (C - Product used for unknown indication - Not applicable - [n/a - n/a - Oral]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007707154&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007707425;Spontaneous;2021-02-24 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Leukopenia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007707425&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007708127;Spontaneous;2021-02-24 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Loss of consciousness (n/a - Unknown - Other Medically Important Condition),<BR><BR>Seizure (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007708127&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007715013;Spontaneous;2021-02-24 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Seizure (0d - Recovered/Resolved - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Product used for unknown indication - Dose not changed - [n/a - n/a - n/a]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Product used for unknown indication - Dose not changed - [n/a - n/a - n/a]),<BR><BR>[PARACETAMOL, PARACETAMOL PH. EUR., PARACETAMOL, CODEINE PHOSPHATE] (S - Product used for unknown indication - Dose not changed - [n/a - n/a - Oral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007715013&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007693010;Spontaneous;2021-02-23 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apnoea (0d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyporesponsive to stimuli (0d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypotonia (0d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypoxia (0d - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])...;ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007693010&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007695165;Spontaneous;2021-02-23 00:00:00;Non Healthcare Professional;European Economic Area;Not available;12-17 Years;Not Specified;No;Female;Drug hypersensitivity (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Hypokinesia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation),<BR><BR>Infection susceptibility increased (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007695165&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007699213;Spontaneous;2021-02-23 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Genital erythema (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Genital swelling (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Lip swelling (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Swelling (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Swelling face (n/a - Unknown - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]),<BR><BR>[MENINGOCOCCAL GROUP C CONJUGATE VACCINE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007699213&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007699493;Spontaneous;2021-02-23 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Benign enlargement of the subarachnoid spaces (n/a - Unknown - ),<BR><BR>Cerebral disorder (n/a - Unknown - ),<BR><BR>Cerebral palsy (n/a - Unknown - Other Medically Important Condition),<BR><BR>Cerebral ventricle dilatation (n/a - Unknown - ),<BR><BR>Cyanosis (n/a - Not Recovered/Not Resolved - Disabling),<BR><BR>Developmental delay (n/a - Not Recovered/Not Resolved - ),<BR><BR>Epilepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Eye movement disorder (n/a - Not Recovered/Not Resolved - ),<BR><BR>Generalised tonic-clonic seizure (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Hypotonia (n/a - Not Recovered/Not Resolved - ),<BR><BR>Loss of personal independence in daily activities (n/a - Unknown - ),<BR><BR>Muscular weakness (n/a - Not Recovered/Not Resolved - ),<BR><BR>Neurological symptom (n/a - Not Recovered/Not Resolved - ),<BR><BR>Neurotoxicity (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Pain (n/a - Unknown - ),<BR><BR>Pallor (n/a - Not Recovered/Not Resolved - ),<BR><BR>Partial seizures (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition),<BR><BR>Petit mal epilepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Postictal state (n/a - Unknown - ),<BR><BR>Product complaint (n/a - Unknown - ),<BR><BR>Product contamination physical (n/a - Unknown - ),<BR><BR>Respiratory arrest (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Screaming (n/a - Not Recovered/Not Resolved - ),<BR><BR>Seizure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Stress (n/a - Unknown - ),<BR><BR>Vaccination complication (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;M-M-RVAXPRO [MEASLES VIRUS ENDERS' EDMONSTON STRAIN (LIVE, ATTENUATED), MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>SYNAGIS [PALIVIZUMAB] (C - Prophylaxis - Not applicable - [n/a - 100mg - n/a - More in ICSR]),<BR><BR>[CORYNEBACTERIUM DIPHTHERIAE CRM197 CARRIER PROTEIN, ALUMINIUM HYDROXIDE, NEISSERIA MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE, CORYNEBACTERIUM DIPHTHERIAE CRM197 CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP C, ALUMINIUM HYDROXIDE, CORYNEBACTERIUM DIPHTHERIAE, NEISSERIA MENINGITIDIS, N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE, ALUMINIUM HYDROXIDE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, ALUMINIUM HYDROXIDE] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007699493&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007702126;Spontaneous;2021-02-23 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apnoea (2min - Recovered/Resolved - Life Threatening, Other Medically Important Condition),<BR><BR>Dyspnoea (2min - Recovered/Resolved - Life Threatening),<BR><BR>Hypersensitivity (2min - Recovered/Resolved - Life Threatening),<BR><BR>Hypotonic-hyporesponsive episode (n/a - Unknown - ),<BR><BR>Injection site rash (n/a - Unknown - ),<BR><BR>Pericardial effusion (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Respiratory arrest (2min - Recovered/Resolved - Life Threatening, Other Medically Important Condition),<BR><BR>Skin discolouration (n/a - Unknown - ),<BR><BR>Staring (n/a - Recovered/Resolved - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007702126&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007681998;Spontaneous;2021-02-22 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Attention deficit hyperactivity disorder (n/a - Not Recovered/Not Resolved - Life Threatening),<BR><BR>Insomnia (n/a - Not Recovered/Not Resolved - Life Threatening),<BR><BR>Productive cough (75d - Recovered/Resolved With Sequelae - Life Threatening);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007681998&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007684609;Spontaneous;2021-02-22 00:00:00;Healthcare Professional;Non European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Diarrhoea (4320min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Irritability (4320min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (4320min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Rash (4320min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (4320min - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007684609&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007680502;Spontaneous;2021-02-21 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Altered state of consciousness (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Eye movement disorder (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Generalised tonic-clonic seizure (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Salivary hypersecretion (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007680502&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007665479;Spontaneous;2021-02-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007665479&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007666773;Spontaneous;2021-02-19 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Anxiety (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Gaze palsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Infantile spasms (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007666773&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007668275;Spontaneous;2021-02-19 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Dermatitis atopic (n/a - Unknown - ),<BR><BR>Epilepsy (n/a - Unknown - Other Medically Important Condition),<BR><BR>Haematuria (n/a - Unknown - ),<BR><BR>Inappropriate schedule of product administration (n/a - Unknown - ),<BR><BR>Nasopharyngitis (n/a - Unknown - ),<BR><BR>Strabismus (n/a - Unknown - ),<BR><BR>Urinary incontinence (n/a - Unknown - ),<BR><BR>Viral infection (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007668275&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007669712;Spontaneous;2021-02-19 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Dermatitis atopic (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition),<BR><BR>Erythema (30min - Unknown - Congenital Anomaly, Other Medically Important Condition),<BR><BR>Skin disorder (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007669712&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007674939;Spontaneous;2021-02-19 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Abdominal pain (n/a - Unknown - Other Medically Important Condition),<BR><BR>Decreased appetite (n/a - Unknown - Other Medically Important Condition),<BR><BR>Diarrhoea (n/a - Unknown - Other Medically Important Condition),<BR><BR>Neutrophil count decreased (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Restlessness (n/a - Unknown - Other Medically Important Condition),<BR><BR>Sleep disorder (n/a - Unknown - Other Medically Important Condition),<BR><BR>Tearfulness (n/a - Unknown - Other Medically Important Condition),<BR><BR>Vaccination site reaction (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007674939&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007652882;Spontaneous;2021-02-18 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Crying (1wk - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Irritability (1wk - Recovering/Resolving - ),<BR><BR>Pyrexia (6d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Sleep disorder (1wk - Recovered/Resolved - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007652882&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007655353;Spontaneous;2021-02-18 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Behaviour disorder (n/a - Recovering/Resolving - ),<BR><BR>Hypertonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Irritability (n/a - Recovering/Resolving - ),<BR><BR>Opisthotonus (n/a - Recovered/Resolved - ),<BR><BR>Tearfulness (n/a - Recovering/Resolving - ),<BR><BR>Vaccination site mass (n/a - Not Recovered/Not Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007655353&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007656195;Spontaneous;2021-02-18 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Febrile convulsion (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007656195&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007657053;Spontaneous;2021-02-18 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Acute respiratory failure (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Anxiety (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Bronchiolitis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Cough (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Decreased appetite (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Dermatitis atopic (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Dyspnoea (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Ear pain (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Hypersensitivity (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Nasopharyngitis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Otitis media acute (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Pneumonia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Respiratory tract infection (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007657053&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007657289;Spontaneous;2021-02-18 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Peripheral swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007657289&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007659215;Spontaneous;2021-02-18 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Abnormal behaviour (n/a - Unknown - ),<BR><BR>Anal sphincter atony (n/a - Not Recovered/Not Resolved - ),<BR><BR>Autism spectrum disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Blepharospasm (n/a - Unknown - ),<BR><BR>Constipation (n/a - Unknown - ),<BR><BR>Crying (n/a - Unknown - ),<BR><BR>Dermatitis atopic (n/a - Unknown - ),<BR><BR>Developmental delay (n/a - Not Recovered/Not Resolved - ),<BR><BR>Epilepsy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Eye movement disorder (n/a - Recovering/Resolving - ),<BR><BR>Fear (n/a - Unknown - ),<BR><BR>Feeling abnormal (n/a - Unknown - ),<BR><BR>Gastroenteritis (n/a - Unknown - ),<BR><BR>Hypotonia (n/a - Unknown - ),<BR><BR>Infection (n/a - Unknown - ),<BR><BR>Insomnia (n/a - Unknown - ),<BR><BR>Irritability (n/a - Unknown - ),<BR><BR>Language disorder (n/a - Unknown - ),<BR><BR>Loss of consciousness (n/a - Unknown - Other Medically Important Condition),<BR><BR>Movement disorder (n/a - Recovering/Resolving - ),<BR><BR>Muscle rigidity (n/a - Not Recovered/Not Resolved - ),<BR><BR>Muscle spasms (n/a - Recovering/Resolving - ),<BR><BR>Muscle spasms (n/a - Unknown - ),<BR><BR>Pain (n/a - Unknown - ),<BR><BR>Partial seizures (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Not Recovered/Not Resolved - ),<BR><BR>Restlessness (n/a - Not Recovered/Not Resolved - ),<BR><BR>Screaming (n/a - Not Recovered/Not Resolved - ),<BR><BR>Skin infection (n/a - Unknown - ),<BR><BR>Sleep disorder (n/a - Unknown - ),<BR><BR>Speech disorder developmental (n/a - Unknown - ),<BR><BR>Spinal instability (n/a - Unknown - ),<BR><BR>Spinal pain (n/a - Unknown - ),<BR><BR>Staring (n/a - Unknown - ),<BR><BR>Stereotypy (n/a - Unknown - ),<BR><BR>Vaginal infection (n/a - Unknown - ),<BR><BR>Visual field defect (n/a - Not Recovered/Not Resolved - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007659215&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007638614;Spontaneous;2021-02-17 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypotonic-hyporesponsive episode (2min - Recovered/Resolved - Other Medically Important Condition);VAXELIS SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007638614&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007642465;Spontaneous;2021-02-17 00:00:00;Healthcare Professional;Non European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Gait disturbance (n/a - Unknown - ),<BR><BR>Limb deformity (n/a - Unknown - ),<BR><BR>Poliomyelitis (n/a - Unknown - Other Medically Important Condition),<BR><BR>Vaccination failure (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007642465&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007644102;Spontaneous;2021-02-17 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular]);ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - n/a - n/a - [n/a - n/a - n/a])...;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007644102&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007645246;Spontaneous;2021-02-17 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Erythema (n/a - Recovered/Resolved - ),<BR><BR>Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Prophylaxis - Unknown - [n/a - n/a - n/a]),<BR><BR>ROTATEQ [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)] (S - Prophylaxis - Unknown - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007645246&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007624271;Spontaneous;2021-02-16 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Anaphylactic shock (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hyporesponsive to stimuli (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - Unknown - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007624271&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007624446;Spontaneous;2021-02-16 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Crying (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyperpyrexia (3d - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007624446&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007625207;Spontaneous;2021-02-16 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Hyperpyrexia (1d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Injection site erythema (1d - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - .5mL - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007625207&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007631696;Spontaneous;2021-02-16 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Febrile convulsion (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007631696&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007619759;Spontaneous;2021-02-15 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;General physical health deterioration (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007619759&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007619894;Spontaneous;2021-02-15 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Upper respiratory tract infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007619894&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007589478;Spontaneous;2021-02-12 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Infantile apnoea (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007589478&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007589584;Spontaneous;2021-02-12 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Infantile apnoea (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007589584&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007602070;Spontaneous;2021-02-12 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Pruritus (11h - Recovered/Resolved - ),<BR><BR>Rash (11h - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [3s - .5mL - Intramuscular - More in ICSR])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007602070&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007582913;Spontaneous;2021-02-11 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Breath sounds abnormal (1d - Recovered/Resolved - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007582913&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007584016;Spontaneous;2021-02-11 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Pyrexia (52h - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site erythema (3d - Recovered/Resolved - ),<BR><BR>Vaccination site oedema (3d - Recovered/Resolved - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Drug withdrawn - [1s - 1{DF} - Intramuscular - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007584016&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007567992;Spontaneous;2021-02-10 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007567992&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007576759;Spontaneous;2021-02-10 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypersensitivity (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007576759&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007552453;Spontaneous;2021-02-09 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Diarrhoea (n/a - Recovered/Resolved - ),<BR><BR>Somnolence (n/a - Recovered/Resolved - ),<BR><BR>Urticaria (n/a - Recovered/Resolved - ),<BR><BR>Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007552453&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007555449;Spontaneous;2021-02-09 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Erythema (3min - Recovered/Resolved - ),<BR><BR>Febrile convulsion (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Generalised tonic-clonic seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Prophylaxis - n/a - [1d - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007555449&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007560589;Spontaneous;2021-02-09 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Crying (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007560589&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007560644;Spontaneous;2021-02-09 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Diarrhoea (n/a - Unknown - Other Medically Important Condition),<BR><BR>Febrile convulsion (n/a - Unknown - Other Medically Important Condition),<BR><BR>Hypertonia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Lividity (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Vomiting (n/a - Unknown - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007560644&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007561489;Spontaneous;2021-02-09 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Apnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Fatigue (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007561489&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007542155;Spontaneous;2021-02-08 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Immune thrombocytopenia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular]),<BR><BR>[ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, ALGELDRATE, NEISSERIA MENINGITIDIS GROUP C, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, TETANUS TOXOID, ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, ALUMINIUM, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, N. MENINGITIDIS GROUP C POLYSACCHARIDE, ALGELDRATE] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007542155&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007542162;Spontaneous;2021-02-08 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Allergy to metals (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Crying (n/a - Unknown - ),<BR><BR>Dermatitis atopic (n/a - Unknown - ),<BR><BR>Dry skin (n/a - Unknown - ),<BR><BR>Eczema infantile (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Pruritus (n/a - Unknown - ),<BR><BR>Psychomotor hyperactivity (n/a - Unknown - ),<BR><BR>Rash macular (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Reaction to excipient (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Vaccination site eczema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Vaccination site induration (n/a - Unknown - ),<BR><BR>Vaccination site nodule (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Vaccination site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Vaccination site pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007542162&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007545942;Spontaneous;2021-02-08 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Apnoeic attack (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Cyanosis (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Hypopnoea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Loss of consciousness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pallor (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007545942&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007548648;Spontaneous;2021-02-08 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Apnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Fatigue (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007548648&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007537296;Spontaneous;2021-02-06 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Crying (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hyperpyrexia (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Urticaria (3d - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007537296&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007538032;Spontaneous;2021-02-06 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Breath holding (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Crying (n/a - Recovering/Resolving - ),<BR><BR>Gait inability (n/a - Recovering/Resolving - ),<BR><BR>Pyrexia (n/a - Recovering/Resolving - );SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007538032&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007528406;Spontaneous;2021-02-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007528406&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007530729;Spontaneous;2021-02-05 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Anxiety (n/a - Unknown - Other Medically Important Condition),<BR><BR>Crying (n/a - Unknown - Other Medically Important Condition),<BR><BR>Diarrhoea (n/a - Unknown - Other Medically Important Condition),<BR><BR>Haematochezia (n/a - Unknown - Other Medically Important Condition),<BR><BR>Screaming (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007530729&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007531208;Spontaneous;2021-02-05 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Screaming (15min - Unknown - Other Medically Important Condition),<BR><BR>Somnolence (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007531208&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007517524;Spontaneous;2021-02-04 00:00:00;Healthcare Professional;Non European Economic Area;Not available;0-1 Month;Not Specified;No;Male;Contusion (n/a - Unknown - ),<BR><BR>Erythema (n/a - Unknown - ),<BR><BR>Extensive swelling of vaccinated limb (n/a - Not Recovered/Not Resolved - ),<BR><BR>Haemorrhage (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007517524&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007518042;Spontaneous;2021-02-04 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Abscess (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007518042&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007521432;Spontaneous;2021-02-04 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Crying (n/a - Unknown - Other Medically Important Condition),<BR><BR>Decreased appetite (n/a - Unknown - Other Medically Important Condition),<BR><BR>Rash (n/a - Unknown - Other Medically Important Condition),<BR><BR>Restlessness (n/a - Unknown - Other Medically Important Condition),<BR><BR>Vomiting projectile (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007521432&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007505034;Spontaneous;2021-02-03 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Child;No;Female;Conjunctivitis (n/a - Unknown - ),<BR><BR>Kawasaki's disease (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Stomatitis (n/a - Unknown - ),<BR><BR>Thrombocytosis (n/a - Unknown - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular - More in ICSR])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007505034&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007507604;Spontaneous;2021-02-03 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007507604&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007508255;Spontaneous;2021-02-03 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Crying (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007508255&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007493567;Spontaneous;2021-02-02 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007493567&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007481928;Spontaneous;2021-02-01 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Vaccination site abscess (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007481928&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007484284;Spontaneous;2021-02-01 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypersensitivity (n/a - Unknown - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007484284&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007484951;Spontaneous;2021-02-01 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Application site erythema (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Injection site induration (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Puncture site oedema (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007484951&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007474368;Spontaneous;2021-01-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypotonic-hyporesponsive episode (1.5h - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007474368&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007475988;Spontaneous;2021-01-30 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hypotonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Loss of consciousness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Seizure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);INFANRIX HEXA POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007475988&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007461686;Spontaneous;2021-01-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Irritability (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Movement disorder (1mo - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Screaming (3d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Sleep disorder (1mo - Recovered/Resolved - Other Medically Important Condition);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007461686&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007464131;Spontaneous;2021-01-29 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypotonia (n/a - Not Recovered/Not Resolved - Disabling);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007464131&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007471639;Spontaneous;2021-01-29 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Cerebral haemorrhage (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Cerebrospinal fluid circulation disorder (n/a - Recovered/Resolved - ),<BR><BR>Eye haemorrhage (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Screaming (n/a - Recovered/Resolved - ),<BR><BR>Seizure (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vitamin K deficiency (n/a - Unknown - ),<BR><BR>Vomiting (n/a - Recovered/Resolved - ),<BR><BR>Von Willebrand's factor activity decreased (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007471639&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007458836;Spontaneous;2021-01-28 00:00:00;Healthcare Professional;European Economic Area;Not available;12-17 Years;Not Specified;No;Male;Immune thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, ALGELDRATE, NEISSERIA MENINGITIDIS GROUP C, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, TETANUS TOXOID, ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, ALUMINIUM, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, N. MENINGITIDIS GROUP C POLYSACCHARIDE, ALGELDRATE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007458836&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007458918;Spontaneous;2021-01-28 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Poor feeding infant (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Screaming (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007458918&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007459782;Spontaneous;2021-01-28 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Bacterial test positive (2wk - Fatal - Results in Death),<BR><BR>Dysphonia (n/a - Unknown - ),<BR><BR>Ear pain (2wk - Unknown - ),<BR><BR>Eye discharge (2wk - Unknown - ),<BR><BR>Insomnia (2wk - Unknown - ),<BR><BR>Nasopharyngitis (n/a - Unknown - ),<BR><BR>Pyrexia (1d - Recovered/Resolved - ),<BR><BR>Pyrexia (n/a - Recovered/Resolved - );SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007459782&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007444972;Spontaneous;2021-01-27 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Female;Developmental delay (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007444972&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007431996;Spontaneous;2021-01-26 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Cystitis escherichia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007431996&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007432016;Spontaneous;2021-01-26 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Febrile convulsion (1h - Recovered/Resolved - Life Threatening),<BR><BR>Pyrexia (n/a - Recovered/Resolved - );SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;NOT AVAILABLE (C - n/a - n/a - [n/a - 240mg - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007432016&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007436019;Spontaneous;2021-01-26 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Febrile convulsion (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007436019&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007429036;Spontaneous;2021-01-25 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Crying (n/a - Unknown - ),<BR><BR>Death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Discomfort (n/a - Unknown - ),<BR><BR>Pyrexia (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);[MYCOBACTERIUM BOVIS, DANISH STRAIN 1331] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007429036&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007429432;Spontaneous;2021-01-25 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Rash erythematous (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Rash pruritic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007429432&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007403824;Spontaneous;2021-01-22 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Vaccination site granuloma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007403824&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007406502;Spontaneous;2021-01-22 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Hypersensitivity (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Musculoskeletal stiffness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Pallor (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Vaccination site erythema (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [5s - 1{DF} - Intramuscular]);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (C - Immunisation - n/a - [5s - 1{DF} - Intramuscular]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007406502&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007406976;Spontaneous;2021-01-22 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Female;Allergy to metals (n/a - Unknown - ),<BR><BR>Cough (n/a - Unknown - ),<BR><BR>Crying (n/a - Unknown - ),<BR><BR>Dermatitis atopic (n/a - Unknown - ),<BR><BR>Dry skin (n/a - Unknown - ),<BR><BR>Eczema (n/a - Not Recovered/Not Resolved - ),<BR><BR>Extra dose administered (n/a - Unknown - ),<BR><BR>Granuloma (n/a - Unknown - ),<BR><BR>Inappropriate schedule of product administration (n/a - Unknown - ),<BR><BR>Injection site eczema (n/a - Not Recovered/Not Resolved - ),<BR><BR>Injection site induration (n/a - Unknown - ),<BR><BR>Injection site nodule (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Injection site pain (n/a - Not Recovered/Not Resolved - ),<BR><BR>Injection site pruritus (n/a - Not Recovered/Not Resolved - ),<BR><BR>Mental disorder (n/a - Unknown - ),<BR><BR>Pigmentation disorder (n/a - Unknown - ),<BR><BR>Pruritus (n/a - Unknown - ),<BR><BR>Psychomotor hyperactivity (n/a - Unknown - ),<BR><BR>Psychomotor skills impaired (n/a - Unknown - ),<BR><BR>Rash macular (n/a - Not Recovered/Not Resolved - ),<BR><BR>Scratch (n/a - Unknown - ),<BR><BR>Screaming (n/a - Unknown - ),<BR><BR>Skin lesion (n/a - Unknown - ),<BR><BR>Skin plaque (n/a - Unknown - ),<BR><BR>Sleep disorder (n/a - Unknown - ),<BR><BR>Wrong product administered (n/a - Unknown - );INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007406976&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007408033;Spontaneous;2021-01-22 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Altered state of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Hypotonia (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Muscle twitching (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pallor (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007408033&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007414007;Spontaneous;2021-01-22 00:00:00;Healthcare Professional;Non European Economic Area;Not available;Not Specified;Infant;No;Not Specified;Blood glucose increased (n/a - Unknown - ),<BR><BR>Neonatal diabetes mellitus (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007414007&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007395547;Spontaneous;2021-01-21 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Pyrexia (150min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation),<BR><BR>Status epilepticus (150min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007395547&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007396440;Spontaneous;2021-01-21 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Encephalitis (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007396440&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007396493;Spontaneous;2021-01-21 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Febrile convulsion (4min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Seizure (4min - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007396493&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007396524;Spontaneous;2021-01-21 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Febrile convulsion (4min - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Seizure (4min - Recovered/Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007396524&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007397829;Spontaneous;2021-01-21 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;Yes;Female;Apathy (10min - Recovered/Resolved - ),<BR><BR>Cold sweat (10min - Recovered/Resolved - ),<BR><BR>Heart rate decreased (10min - Recovered/Resolved - ),<BR><BR>Hypotonia (10min - Recovered/Resolved - ),<BR><BR>Muscle spasms (n/a - Unknown - ),<BR><BR>Pallor (10min - Recovered/Resolved - ),<BR><BR>Screaming (10min - Recovered/Resolved - ),<BR><BR>Seizure (n/a - Unknown - Other Medically Important Condition),<BR><BR>Syncope (n/a - Unknown - Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007397829&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007385068;Spontaneous;2021-01-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Myoclonus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Unknown]);[PNEUMOCOCCAL CONJUGATE VACCINE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007385068&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007385304;Spontaneous;2021-01-20 00:00:00;Non Healthcare Professional;European Economic Area;Not available;3-11 Years;Child;No;Female;Injection site erythema (7d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Puncture site oedema (7d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Puncture site pruritus (7d - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [2s - 1{DF} - Intramuscular - More in ICSR]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007385304&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007389530;Spontaneous;2021-01-20 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Hypotonia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Lethargy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pallor (n/a - Recovered/Resolved - ),<BR><BR>Sensory disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007389530&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007375659;Spontaneous;2021-01-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Cyanosis (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonic-hyporesponsive episode (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Listless (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [1d - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007375659&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007375686;Spontaneous;2021-01-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Depressed level of consciousness (n/a - Unknown - Life Threatening);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - n/a - n/a - [n/a - n/a - Oral])...;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007375686&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007376078;Spontaneous;2021-01-19 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Depressed level of consciousness (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Listless (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Vomiting (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007376078&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007376432;Spontaneous;2021-01-19 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Vaccination site abscess (n/a - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007376432&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007368770;Spontaneous;2021-01-18 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;0-1 Month;Not Specified;No;Male;Crying (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Erythema (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Feeling hot (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Hyperhidrosis (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Inflammation (n/a - Unknown - Disabling, Other Medically Important Condition),<BR><BR>Peripheral swelling (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>Strabismus (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition),<BR><BR>VIth nerve paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - Oral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007368770&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007357294;Spontaneous;2021-01-15 00:00:00;Non Healthcare Professional;Non European Economic Area;Not available;0-1 Month;Not Specified;No;Male;Pruritus (n/a - Unknown - Other Medically Important Condition),<BR><BR>Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Skin disorder (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]),<BR><BR>ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007357294&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007361468;Spontaneous;2021-01-15 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Risus sardonicus (12h - Recovered/Resolved - Caused/Prolonged Hospitalisation);VAXELIS SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007361468&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007350268;Spontaneous;2021-01-14 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Insomnia (n/a - Recovered/Resolved - ),<BR><BR>Irritability (14d - Recovered/Resolved - ),<BR><BR>Psychomotor skills impaired (14d - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Recovered/Resolved - ),<BR><BR>Restlessness (14d - Recovered/Resolved - ),<BR><BR>Somnolence (2d - Recovered/Resolved - ),<BR><BR>Tearfulness (14d - Recovered/Resolved - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [10s - 1{DF} - Intramuscular]);ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (C - Immunisation - n/a - [1min - 1.5mL - Oral]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007350268&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007353404;Spontaneous;2021-01-14 00:00:00;Non Healthcare Professional;European Economic Area;Not available;Not Specified;Child;No;Female;Epilepsy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);VAXELIS SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA], POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]),<BR><BR>[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]),<BR><BR>[DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007353404&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007333812;Spontaneous;2021-01-12 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Bacterial test positive (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>C-reactive protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Crying (n/a - Recovered/Resolved - ),<BR><BR>Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Respiratory arrest (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Respiratory disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Respiratory rate decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Urinary tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Urine analysis abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>White blood cells urine positive (n/a - Unknown - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular]),<BR><BR>PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007333812&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007335654;Spontaneous;2021-01-12 00:00:00;Healthcare Professional;Non European Economic Area;Not available;65-85 Years;Not Specified;Yes;Male;Lip oedema (510min - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pruritus (510min - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Rash maculo-papular (510min - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Toxic skin eruption (510min - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Urticaria (510min - Recovered/Resolved - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])...;ESOMEPRAZOLE [ESOMEPRAZOLE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>[FOLINIC ACID] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>[PHENOXYMETHYLPENICILLIN POTASSIUM] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>[SULFAMETHOXAZOLE, TRIMETHOPRIM] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>[URSODEOXYCHOLIC ACID] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown]),<BR><BR>[VALACICLOVIR, VALACICLOVIR HYDROCHLORIDE] (C - Prophylaxis - Unknown - [n/a - n/a - Unknown]),<BR><BR>[VITAMIN D] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[ZINC] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007335654&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007328118;Spontaneous;2021-01-11 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Status epilepticus (1h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Unknown - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007328118&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007325078;Spontaneous;2021-01-10 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Blister (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Erythema (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Pemphigus (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Skin exfoliation (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Skin swelling (n/a - Recovering/Resolving - Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a]);[DIMETINDENE MALEATE] (C - n/a - n/a - [n/a - 4{DF} - Oral]),<BR><BR>[FLUDROCORTISONE ACETATE, GRAMICIDIN, NEOMYCIN] (C - n/a - n/a - [n/a - 2{DF} - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007325078&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007321061;Spontaneous;2021-01-08 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Opisthotonus (n/a - Unknown - Other Medically Important Condition),<BR><BR>Pyrexia (n/a - Unknown - );HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007321061&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007321348;Spontaneous;2021-01-08 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Febrile convulsion (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007321348&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007314851;Spontaneous;2021-01-07 00:00:00;Healthcare Professional;European Economic Area;Not available;0-1 Month;Not Specified;No;Male;Blindness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Bradycardia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Brain oedema (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Cerebral haemorrhage (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Child maltreatment syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Epilepsy (73d - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Gaze palsy (73d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Generalised tonic-clonic seizure (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling),<BR><BR>Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Hypotonic-hyporesponsive episode (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Loss of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Respiratory arrest (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Retinal haemorrhage (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Rhinitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Upper respiratory tract infection bacterial (n/a - Unknown - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1d - n/a - Unknown]),<BR><BR>ROTATEQ [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)] (S - Immunisation - Not applicable - [1d - n/a - Subcutaneous]),<BR><BR>[PNEUMOCOCCAL CONJUGATE VACCINE] (S - Immunisation - Not applicable - [1d - n/a - Unknown]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007314851&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007315671;Spontaneous;2021-01-07 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Acute haemorrhagic oedema of infancy (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Pyrexia (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007315671&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007306692;Spontaneous;2021-01-06 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Crying (n/a - Unknown - ),<BR><BR>Developmental regression (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Restlessness (n/a - Unknown - ),<BR><BR>Thrombocytosis (n/a - Unknown - );HEXACIMA [HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;[COLECALCIFEROL] (C - n/a - n/a - [n/a - 1[drp] - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007306692&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007296985;Spontaneous;2021-01-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Hypotonic-hyporesponsive episode (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007296985&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007297272;Spontaneous;2021-01-05 00:00:00;Healthcare Professional;European Economic Area;Not available;3-11 Years;Not Specified;No;Male;Myoclonus (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Oculogyric crisis (n/a - Recovering/Resolving - Other Medically Important Condition),<BR><BR>Psychomotor skills impaired (n/a - Recovering/Resolving - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007297272&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007297533;Spontaneous;2021-01-05 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Hyperpyrexia (n/a - Recovered/Resolved - Other Medically Important Condition),<BR><BR>Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007297533&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007298259;Spontaneous;2021-01-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Drug ineffective (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Pertussis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition),<BR><BR>Vaccination failure (n/a - Unknown - Other Medically Important Condition);INFANRIX HEXA POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007298259&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007298279;Spontaneous;2021-01-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Male;Cellulitis (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007298279&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007299968;Spontaneous;2021-01-05 00:00:00;Non Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Campylobacter gastroenteritis (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Exanthema subitum (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Febrile convulsion (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pyrexia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Dose not changed - [5s - 1{DF} - Intramuscular]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007299968&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007301962;Spontaneous;2021-01-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Not Specified;Ear canal injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Pallor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Rhinitis (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Skin discolouration (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Throat irritation (n/a - Unknown - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007301962&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007303276;Spontaneous;2021-01-05 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Injection site abscess (3d - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Injection site inflammation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Injection site pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Injection site swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation),<BR><BR>Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);SYNFLORIX SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007303276&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007293150;Spontaneous;2021-01-04 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Infant;No;Female;Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation),<BR><BR>Infantile spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007293150&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007294783;Spontaneous;2021-01-04 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Anaphylactic shock (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Crying (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition),<BR><BR>Skin discolouration (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation),<BR><BR>Unresponsive to stimuli (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...;Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007294783&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007289791;Spontaneous;2021-01-02 00:00:00;Healthcare Professional;Non European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Male;Generalised tonic-clonic seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACT.) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[PNEUMOCOCCAL CONJUGATE VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]),<BR><BR>[ROTAVIRUS VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a]);Not reported;"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007289791&_xpt=1&_xf=pdf"">ICSR</a>"
EU-EC-10007287654;Spontaneous;2021-01-01 00:00:00;Healthcare Professional;European Economic Area;Not available;2 Months - 2 Years;Not Specified;No;Female;Rectal haemorrhage (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);HEXYON [DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, TETANUS PROTEIN, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, TETANUS PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular]),<BR><BR>SYNAGIS [PALIVIZUMAB] (S - Prophylaxis - Not applicable - [n/a - 15mg/kg - Intramuscular]);[ASCORBIC ACID, ERGOCALCIFEROL, ALPHATOCOPHEROL ACETATE, VITAMIN A CONCENTRATE (OILY FORM), SYNTHETIC, ASCORBIC ACID, ERGOCALCIFEROL, RETINOL, ALPHATOCOPHEROL ACETATE] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[PHYTOMENADIONE] (C - n/a - n/a - [n/a - n/a - n/a]),<BR><BR>[SODIUM FEREDETATE] (C - n/a - n/a - [n/a - n/a - n/a]);"<a target=""_blank"" href=""https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007287654&_xpt=1&_xf=pdf"">ICSR</a>"